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ABSTRACT 
Endothelial dysfunction is a major risk factor for the development of 
cardiovascular diseases, and aging is associated with a gradual decline in endothelial 
function. Furthermore, endothelial dysfunction in arteries and arterioles supplying 
skeletal muscle has been implicated in the decline in exercise capacity with aging. 
Defined as an imbalance between the production and degradation of nitric oxide (NO), 
limited NO bioavailability is the hallmark characteristic of endothelial dysfunction. 
Production of NO is controlled by the enzyme endothelial nitric oxide synthase (eNOS), 
which is regulated in part by post-translational protein modifications.  
The purpose of this research was to examine the effect of vascular heterogeneity, 
aging, and endurance exercise training on eNOS-associated protein:protein interactions. 
Caveolin-1 (Cav1) is a negative regulator of eNOS activity, so that NO production is 
suppressed when Cav1 is bound to eNOS. Conversely, calmodulin (CaM) and heat-
shock protein 90 (Hsp90) are positive regulators of eNOS activity, thus increasing eNOS 
activity and NO production when either are bound to eNOS. Co-immunoprecipitation 
was used to determine protein:protein interactions among eNOS and its regulatory 
proteins throughout the arterial network, from the aorta to third order skeletal muscle 
arterioles. Results show that eNOS-associated protein:protein interactions vary 
throughout the arterial network, and Cav1:eNOS and CaM:eNOS interactions are altered 
with aging. Additionally, endurance exercise training has no effect on the protein:protein 
interactions examined. In conclusion, eNOS regulation via protein:protein interactions 
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appears to be vessel-specific, and aging has a heterogeneous effect on protein:protein 
interactions throughout the arterial network. 
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CHAPTER I 
INTRODUCTION 
1.1 Identification of endothelium-derived relaxing factor as nitric oxide 
The vascular endothelium is composed of a monolayer of cells lining the inner 
wall of blood vessels separating vascular smooth muscle from the circulating blood 
(Luescher and Barton 1997). This layer of cells was traditionally believed to be an inert 
physical barrier until groundbreaking experiments by Furchgott and Zawadzki 
demonstrated an active role of the endothelium in maintaining vascular homeostasis 
(Furchgott and Zawadzki 1980). In this seminal study, rabbit aortic rings that had their 
endothelial cells removed were exposed to acetylcholine (ACh), which resulted in the 
development of tension through the action of ACh on the muscarinic receptors on 
vascular smooth muscle. However, when care was taken to maintain the endothelium 
intact, ACh acted via the endothelium through a then unknown mechanism to cause 
relaxation of the aortic rings. From these experiments, Furchgott and Zawadzki 
concluded that the endothelium was capable of producing a substance that causes 
relaxation of the surrounding vascular smooth muscle in response to ACh stimulation of 
the endothelium. This substance was termed “endothelium-derived relaxing factor” 
(EDRF). Expanding on Furchgott and Zawadzki’s discovery, this substance was later 
identified to be nitric oxide (NO) (Palmer et al. 1987; Ignarro et al. 1987a). Additional 
research has identified a number of EDRF’s that are now known to play a role in 
mediating endothelium-dependent vasodilation, including cyclooxygenase (COX)-
derived prostacyclin (PGI2) (Holtz et al. 1984), and endothelium-derived hyperpolarizing 
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factor (EDHF) (Brandes et al. 2000). Furthermore, studies have also demonstrated a role 
of the endothelium in producing vasoconstrictors, including endothelin-1(Boulanger and 
Luscher 1990; Lüscher et al. 1990). Collectively, these studies were among the first to 
establish the role of the vascular endothelium as a paracrine organ, able to respond to 
chemical and mechanical stimuli by producing and releasing vasoactive substances to 
cause local vasodilation or vasoconstriction. This enables blood flow to the perfused 
tissue to be precisely regulated in order to match oxygen delivery to metabolic demand, 
maintaining local vascular homeostasis.  
1.2 Roles of nitric oxide in vascular function 
Since the confirmation of NO as an EDRF, several other physiological roles of 
NO have been identified. In addition to regulating vascular tone NO also helps prevent 
the development of atherosclerotic lesions, and aids in the process of new blood vessel 
growth, all in order to maintain vascular homeostasis (Murohara et al. 1998; Hogg et al. 
1993). Human studies have established the importance of NO bioavailability in 
maintaining endothelial function and cardiovascular health. Impaired NO-mediated 
endothelial function has been demonstrated with aging and in pathological conditions 
including obesity, hypertension, insulin resistance, and high cholesterol (Higashi et al. 
2001; Heitzer et al. 2000; Casino et al. 1993). These conditions are all risk factors for 
developing cardiovascular diseases, with impaired NO bioavailability a potential link 
between the pathology of the original disease and subsequent cardiovascular 
complications (Li and Förstermann 2000). These studies demonstrate the clinical 
importance of NO as a regulator of vascular function and healthy endothelial function. 
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Vascular tone is maintained by the balance of vasodilators and vasoconstrictors 
produced and present in the vasculature. Of these, NO is a key endothelium-derived 
vasodilator that acts on the adjacent vascular smooth muscle to increase intracellular 
cyclic GMP levels. Subsequently, reduced intracellular calcium causes the vascular 
smooth muscle to relax, resulting in vasodilation (Ignarro et al. 1987b). Endothelial 
nitric oxide synthase (eNOS) is a calcium-dependent enzyme responsible for catalyzing 
the conversion of L-arginine to NO and L-citrulline (Palmer et al. 1988; Ignarro 1990). 
In addition to L-arginine, numerous cofactors, including tetrahydrobiopterin (BH4), 
NADPH, FAD, and FMN are also required for this reaction to occur (Michel and Feron 
1997).  NO-mediated, endothelium-dependent vasodilation has been demonstrated in 
response to a number of physiological agonists, including ACh, vascular endothelial 
growth factor (VEGF), bradykinin, and histamine. While the intracellular signaling 
pathways for each agonist are distinct, all result in an increase in the intracellular 
calcium concentration in endothelial cells.   
Endothelium-dependent, NO-mediated vasodilation can also be induced by 
physical forces acting on the wall of blood vessels. Shear stress created by blood flowing 
across the luminal surface of endothelial cells is an important mechanical signal 
controlling local vasodilation (Koller et al. 1993). Additionally, shear stress is a key 
mechanism responsible for stimulating NO release in response to increases in blood 
flow. Shear stress has been shown to cause calcium-dependent NO synthesis in 
endothelial cells (Xiao et al. 1997). This is of particular interest in the study of blood 
flow regulation during exercise, as the increase in blood flow to actively contracting 
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skeletal muscles causes local vasodilation, allowing a greater oxygen and nutrient 
delivery to actively contracting skeletal muscles during exercise.  
There is also evidence suggesting that pulsatile changes in intraluminal pressure 
on vessel walls can induce endothelium-mediated NO release. This effect was originally 
demonstrated by Awolesi et al. (1994) who demonstrated that increasing cyclic strain on 
the surface of the endothelial cells increased eNOS activity and NO production in 
cultured cells. Following this finding,  Recchia et al. (1996) demonstrated that acute 
increases in intraluminal pulsatile pressure in vivo enhanced endothelium-derived NO 
release in dog coronary arteries. While this mechanism of regulating endothelial NO 
production remains to be fully examined, results of these studies suggest that acute 
increases in intraluminal pressure may be an important mechanism accounting for the 
hyperemic response to exercise, and promote healthy endothelial function. 
Nitric oxide is generally considered to be an athero-protective molecule, meaning 
that its bioavailability can prevent or mitigate the development of atherosclerosis and 
subsequent cardiovascular disease. This effect of NO is due, in part, to its anti-adhesion 
effects on platelets and leukocytes (Tsao et al. 1994; Freedman et al. 1997) and 
inhibitory effects on smooth muscle cell proliferation (Garg and Hassid 1989), which is 
an early step in the development of atherosclerosis. The presence of NO in the vascular 
endothelium is critical to prevent the accumulation of platelets and leukocytes in the wall 
of blood vessels at the site of endothelial injury, whereas impaired NO-mediated 
endothelial function is an early event in the pathogenesis of atherosclerosis (Reddy et al. 
1994; Zeiher et al. 1991b). Evidence from Hogg et al. (1993) also demonstrate a role of 
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NO in inhibiting low density lipoprotein (LDL) aggregation and oxidation and uptake by 
macrophages in vitro. In addition to these effects, NO also inhibits the proliferation of 
vascular smooth muscle at the site of vascular injury (Janssens et al. 1998). These 
studies show that the presence of NO in the endothelium protects against the 
pathogenesis of atherosclerosis by preventing the accumulation of platelets, leukocytes, 
and LDL cholesterol that leads to the development of the plaque in the wall of the vessel 
that is characteristic of atherosclerosis. Importantly, these studies emphasize the 
protective effects of NO against the development of cardiovascular diseases. 
Finally, NO plays an important signaling role in angiogenesis in response to 
tissue ischemia and the activation of vascular endothelial growth factor (VEGF) (Cooke 
2003; Murohara et al. 1998). The process of angiogenesis is stimulated by local tissue 
ischemia in an effort to maintain blood flow and oxygen delivery to the ischemic tissue. 
VEGF is thought to be the primary stimulus secreted by ischemic tissue that results in 
endothelial NO production (Papapetropoulos et al. 1997). VEGF acts on tyrosine kinase 
receptors on the surface of endothelial cells and activates the intracellular PI3K/Akt 
second messenger cascade (Achen et al. 1998; Dimmeler et al. 2000). As a result, Akt 
phosphorylates eNOS on serine residue 1177, an activating site on the eNOS protein 
(Dimmeler et al. 2000). Supporting evidence for these findings include a study by Zicher 
et al. (Ziche et al. 1997) who showed that inhibition of eNOS activity with L-NG-
nitroarginine methyl ester (L-NAME) inhibited angiogenesis in rabbit corneal vessels. 
Furthermore, in eNOS knockout mice, VEGF-induced angiogenesis was impaired 
compared to wild-type mice, confirming the role of eNOS and NO in VEGF-induced 
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angiogenesis (Fukumura et al. 2001). These studies establish the critical role of eNOS-
derived NO production in initiating tissue angiogenesis as a mechanism to restore 
adequate blood flow and nutrient delivery to ischemic tissue or to increase skeletal 
muscle angiogenesis as an adaptation to exercise training. 
1.3 Regulation of nitric oxide bioavailability 
Nitric oxide bioavailability is determined by the balance between NO production 
and NO degradation. Proper balance of NO produced versus NO degraded is critical in 
maintaining local vascular homeostasis and ensuring adequate tissue perfusion so that 
oxygen and nutrient delivery is precisely matched to oxygen and nutrient demand of the 
perfused tissue. An imbalance between the production and degradation of NO leads to 
endothelial dysfunction, a condition which increases the risk of developing 
cardiovascular diseases (Halcox et al. 2002; Celermajer et al. 1994a). The bioavailability 
of NO is regulated by a number of physiological factors, including the presence or 
absence of enzyme substrates and cofactors, endothelial cell agonists, and mechanical 
stimuli, which act in concert to maintain vascular endothelial homeostasis (Figure 1.1).  
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As mentioned in the previous sections, endothelial cell agonists such as ACh and 
VEGF increase eNOS enzyme activity and NO production. Additionally, mechanical 
stimuli such as shear stress and intraluminal pulsatile pressure also increase eNOS 
enzyme activity and NO production, improving local vascular homeostasis (Woodman et 
al. 2005; Woodman et al. 2007). The mechanical stimulation of eNOS activity may be an 
important mechanism accounting for the hyperemic response to exercise in active 
skeletal muscles, which will be discussed in detail in a later section.  
NO degradation can occur via several different mechanisms. However, these 
mechanisms may interact with each other and in pathological conditions, may exacerbate 
each other. For example, oxidative stress in the vascular endothelium may deplete 
tetrahydrobiopterin (BH4), an important co-factor for eNOS enzyme activity (Alp and 
Channon 2004; Bendall et al. 2005). This in turn results in “eNOS uncoupling”, meaning 
Figure 1.1 
Figure 1.1. Mechanisms regulating  nitric oxide bioavailability. 
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that eNOS becomes an oxidant-producing enzyme, further contributing to the oxidative 
stress in the endothelium (Landmesser et al. 2003).  
 NO is rapidly scavenged by reactive oxygen species (ROS) present in the 
vasculature. ROS are oxygen-containing ions that are present in nearly all tissues. 
Because they carry a negative charge, ROS are highly reactive and rapidly combine with 
other molecules in oxidation-reduction reactions where the original ROS is reduced and 
another molecule, such as NO, is oxidized (Beckman et al. 1990). Additionally, ROS 
may also have endothelium-dependent and independent vasoconstrictive effects, 
although this effect does not appear to be true of all ROS or in all vascular beds. Trott et 
al. (2011) have demonstrated endothelium-dependent vasorelaxation in response to the 
ROS hydrogen peroxide (H2O2) in soleus feed arteries from young and old rats. The 
vasoactive properties of H2O2 appear to vary with the vascular bed, as it causes 
vasodilation in porcine coronary arteries (Barlow and White 1998), rat mesenteric 
arteries (Barlow and White 1998), and  rat skeletal muscle arteries and arterioles (Trott 
et al. 2011; Sindler et al. 2009), while causing vasoconstriction in porcine coronary 
arterioles (Thengchaisri et al. 2006). However, care should be taken when interpreting 
these findings as there may be a species effect on the role of H2O2 in vasoregulation.  
Superoxide anion (O2
.-) is another ROS that is a product of cellular respiration, 
making it ubiquitous in the body. NAD(P)H oxidase and xanthine oxidase are two of the 
primary enzymes responsible for the production of O2
.- in the endothelium, although 
NADPH oxidase appears to be primarily responsible for elevated ROS (Donato et al. 
2007). When O2
.- reacts with NO, peroxynitrite (ONOO-) is produced (Beckman et al. 
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1990). Under normal conditions in healthy endothelium, levels of ROS are maintained 
by antioxidant enzymes including superoxide dismutase, and catalase (Beckman et al. 
1988). However, in many pathological conditions, ROS concentrations exceed the ability 
of antioxidants to scavenge the ROS, leading to tissue damage (Guzik et al. 2000).  ROS 
in the endothelium  has been shown to be elevated with aging (Trott et al. 2011), 
smoking (Tanriverdi et al. 2006), and disease states (Heitzer et al. 2001; Ceriello et al. 
2002). Consequently, the presence of excess ROS is one mechanism that has been 
extensively examined as a mechanism resulting in NO-dependent endothelial 
dysfunction in these conditions. 
In addition to oxidative stress, in the absence of adequate levels of its co-factor 
BH4, eNOS is also capable of producing O2
.-, further contributing to oxidative stress in 
the surrounding tissue and limiting NO bioavailability (Alp and Channon 2004; 
Cosentino and Lüscher 1999). This process, known as eNOS uncoupling, has been 
shown to be another possible mechanism of NO-dependent endothelial dysfunction with 
aging and Type II diabetes (Heitzer et al. 2000). Indeed, increasing the availability of 
BH4 in vivo improves NO-mediated endothelial function in both animals and humans 
(Eskurza et al. 2005). The rate-limiting step in the production of BH4 is the enzyme 
guanosine triphosphate-cyclohydrolase (GTP-CH). In vitro studies suggest that 
increasing GTP-CH gene expression increases BH4 production, suggesting another 
possible mechanism for limited BH4 bioavailability. In fact, extensive work by Alp and 
colleagues has demonstrated a therapeutic effect of GTP-CH gene overexpression on 
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NO-mediated endothelial function in atherosclerosis and diabetes (Alp et al. 2004; Alp et 
al. 2003).  
In addition to the availability of BH4, the presence of the substrate for eNOS, L-
arginine, has also been implicated in limiting NO bioavailability in the endothelium 
(Rees et al. 1989). Several studies have shown a beneficial effect of L-arginine 
supplementation on NO-mediated endothelial function in individuals with cardiovascular 
diseases (Lerman et al. 1998; Hambrecht et al. 2000a; Drexler et al. 1991). It is 
hypothesized that in conditions of impaired NO bioavailability supplementation with L-
arginine may increase NO production to compensate for the rapid NO degradation by 
ROS (Hambrecht et al. 2000a). Additionally, L-arginine may also act as an antioxidant 
so that NO is preserved in pathological conditions (Huk et al. 1997; Böger et al. 1998). 
Post-translational modifications to the eNOS protein also play a role in 
maintaining NO bioavailability. Phosphorylation of eNOS can either enhance NO or 
suppress NO production, depending on which residue is phosphorylated (Mount et al. 
2007). A study by Trott et al. (Trott et al. 2013) demonstrated a link between eNOS 
phosphorylation on the enzyme activating residue Ser1177 and NO-mediated endothelial 
function with ACh in young and old soleus feed arteries. In contrast, there have been 
fewer studies examining the effect on NO bioavailability of phosphorylation of eNOS on 
its negative regulatory residue, Thr495. While Thr495 has been shown to suppress eNOS 
enzyme activity in vitro (Fleming et al. 2001), to our knowledge this finding has yet to 
be confirmed in vivo. Regardless, these studies suggest that post-translational eNOS 
phosphorylation is a critical mechanism for maintaining NO bioavailability. 
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Another post-translational mechanism regulating eNOS enzyme activity is its 
interaction with other intracellular proteins. In endothelial cells, eNOS activity is 
regulated by caveolin-1 (Cav1), a negative regulator of eNOS activity (Du and Chen 
2009; Smith et al. 2006; Michel et al. 1997a), as well as heat-shock protein-90 (Hsp90), 
and calmodulin (CaM), positive regulators of eNOS activity (Garcia-Cardena et al. 1998; 
Michel et al. 1997a). Conditions that result in enhanced eNOS interaction with Cav1 
and/or reduced interactions with Hsp90 and CaM may reduce NO bioavailability. A role 
of protein:protein interactions between eNOS and its regulatory proteins have been 
demonstrated in vitro. Additionally, in vivo studies have linked an increase in 
Cav1:eNOS interaction with reduced NO bioavailability and impaired endothelial 
function with aging. Furthermore, there is some evidence that exercise training enhances 
Hsp90:eNOS activity in skeletal muscle (Harris et al. 2008); however the implications 
for NO bioavailability and NO-mediated vascular endothelial function remain to be 
determined.  
Maintaining NO bioavailability is a critical mechanism for maintaining vascular 
homeostasis. Conditions resulting in reduced NO bioavailability and impaired NO-
mediated endothelial function increase an individual’s risk for developing cardiovascular 
disease independent of the presence of any other cardiovascular risk factors.  
1.4 Clinical implications of nitric oxide deficiency 
Cardiovascular diseases are a leading cause of death among adults in the United 
States, accounting for one third of all deaths in the year 2009 (Go et al. 2013). 
Additionally, healthcare and lost-productivity costs attributable to cardiovascular 
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diseases are estimated to be $312.6 billion per year (Go et al. 2013). Endothelial 
dysfunction is an independent risk factor for developing cardiovascular disease, and 
occurs early in the process of cardiovascular disease development (Celermajer et al. 
1994a). Aging is also an independent risk factor for cardiovascular disease, and is 
associated with a decline in vascular endothelial function, further compounding the risk 
of developing cardiovascular disease with age (Celermajer et al. 1994c). Endothelial 
damage is the initiating step in the process of atherosclerosis (Ross and Glomset 1976; 
Ludmer et al. 1986) and endothelial dysfunction is present even when there is no other  
clinical evidence of atherosclerotic lesions (Celermajer et al. 1994a). The age-related 
decline in endothelial function has been demonstrated in various vascular beds in older 
humans and aged animal models (Küng and Lüscher 1995; Muller-Delp et al. 2002a; 
Cernadas et al. 1998; Kang et al. 2009a; Celermajer et al. 1994c; van der Loo et al. 
2000a; Trott et al. 2013; Trott et al. 2011; Woodman et al. 2003). Similar to the decline 
in endothelial function, there is also an age-related decline in aerobic capacity and 
exercise tolerance (Fleg et al. 2005; Fitzgerald et al. 1997). Lack of physical activity 
throughout the lifespan may account for the reduced exercise tolerance with aging; 
furthermore lifelong physical inactivity may also account for the age-related impairment 
in NO-mediated endothelial function. The presence of endothelial dysfunction 
throughout the arterial vascular tree is not only a risk factor for cardiovascular disease, 
but is also a potential mechanism accounting for the impaired endurance exercise 
tolerance seen with aging. In large elastic conduit arteries like the aorta and brachial 
artery, endothelial dysfunction is linked to the development of atherosclerosis and 
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cardiovascular disease risk (Mullen et al. 2001; Woo et al. 1997). Downstream of the 
conduit arteries, endothelial dysfunction in skeletal muscle resistance arteries and 
arterioles may result in impaired exercise hyperemia, potentially reducing oxygen 
delivery to actively contracting skeletal muscles and limiting maximal exercise capacity 
(Musch et al. 2004). However, endurance exercise training has been shown to attenuate 
the effects of aging on endothelial function and cardiovascular disease risk while also 
improving endothelial function in skeletal muscle resistance vessels (Eskurza et al. 2004; 
DeSouza et al. 2000; Hambrecht et al. 2000b; Trott et al. 2009; Spier et al. 2004). Thus 
the beneficial effects of endurance exercise training have systemic effects on vascular 
endothelium, and specifically improve cardiovascular risk factors and exercise tolerance. 
In pathological conditions including cardiovascular diseases, Type I and II 
diabetes, smoking, hyperlipidemia, hypertension, and aging, the balance between NO 
production and degradation is disrupted so that NO-mediated vasodilator responses to 
stimuli are blunted. This endothelial dysfunction compounds the original condition by 
increasing the risk of developing cardiovascular complications, further contributing to 
the healthcare costs associated with cardiovascular diseases. 
1.5 Mechanisms of nitric oxide deficiency 
 Impaired endothelial function can be attributed in part to reduced NO 
bioavailability, the mechanisms of which have been discussed in a previous section. NO 
deficiency can result from insufficient NO production via eNOS, increased NO 
degradation by oxidative stress, or a combination of mechanisms suppressing NO 
production and increasing NO degradation. This may be due to a number of factors, 
13 
 
including lack of substrate or cofactors for eNOS, reduced eNOS protein content, and/or 
post-translational modifications of eNOS that suppress its enzyme activity.  
In a study conducted by van Haperen et al, (van Haperen et al. 2002) eNOS 
overexpression resulted in reductions in blood pressure and markers of atherosclerosis in 
apo-E deficient mice, suggesting that restoring eNOS function and NO bioavailability 
improves cardiovascular risk factors.  However, as will be discussed in more detail in the 
following section, in some conditions, eNOS protein content may be elevated compared 
to healthy endothelium, possibly as a compensatory mechanism to maintain 
endothelium-dependent NO production in the presence of impaired NO signaling. 
Additionally, NO degradation by ROS is elevated in many pathological conditions, 
likely due to an increase in ROS generation and a decrease in the antioxidant capacity of 
the endothelium.  
Interventions that increase antioxidant availability, like ascorbic acid infusion, 
have been shown to improve NO-mediated endothelial function (Eskurza et al. 2004). 
Because endothelial dysfunction has been implicated in several diseases and conditions, 
it is likely that the mechanisms accounting for NO deficiency may vary with the disease 
or condition being investigated. Additionally, the mechanisms of NO deficiency 
throughout the arterial tree may be vessel-specific. The vascular heterogeneity of the 
vasoactive response to H2O2 has already been discussed in a previous section. Changes 
in eNOS protein content with age also appear to be vessel specific (Woodman et al. 
2002). Results of these studies support the concept of the heterogeneous nature of 
vascular endothelial function and dysfunction, and that other mechanisms of impaired 
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NO bioavailability may follow a similar pattern. This heterogeneous phenotype of 
impaired NO bioavailability adds a layer of complexity to the study of the mechanisms 
of endothelial dysfunction.  
1.6 Endothelium, nitric oxide and aging 
 Endothelial function declines with age, thus increasing the risk of cardiovascular 
diseases with advancing age (Celermajer et al. 1994a). As a consequence, cardiovascular 
diseases are the leading cause of mortality in adults over the age of 65 (Gorina Y 2006). 
Impaired NO-mediated endothelial function with aging has been demonstrated in various 
vascular beds in both humans and animal models of aging. The mechanisms accounting 
for impaired NO-mediated endothelial function with age appear to be varied as well. 
Furthermore, the implications for age-associated endothelial dysfunction are multi-
faceted. For example, age-related endothelial dysfunction in resistance-sized arteries 
feeding skeletal muscles likely contributes to reduced exercise tolerance in older adults 
(Woodman et al. 2002; DeSouza et al. 2000). As a result, this may contribute to the 
established age-related decline in maximal aerobic capacity (Wilson and Tanaka 2000; 
Fitzgerald et al. 1997). The importance of maintaining aerobic capacity with age has 
been demonstrated by Sui et al. (2007), who showed a negative correlation between 
aerobic capacity and all-cause mortality in adults aged 60 and over. Additionally, 
maintaining aerobic capacity with aging may allow older adults to maintain an 
independent lifestyle until very late in life. 
 In large elastic conduit arteries like the brachial artery, impaired endothelial 
function is linked to the development of atherosclerosis and arterial stiffening with age 
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(Taddei et al. 1995). As outlined in a previous section, endothelial dysfunction occurs 
early in the process of atherosclerosis. The development of endothelial dysfunction and 
subsequent atherosclerosis increase the likelihood of having a serious cardiovascular 
event, potentially resulting in significant healthcare costs and loss of independence in 
older adults. 
1.7 Mechanisms of age-induced endothelial dysfunction 
Several mechanisms accounting for impaired NO bioavailability in the 
endothelium have been discussed in section 1.3. Many of these same mechanisms have 
been investigated in order to determine the cause(s) of the age-related decline in NO-
mediated endothelial function (Table 1.1).  
One potential mechanism accounting for the age-related decline in endothelial 
function is reduced eNOS protein transcription and translation. However, results from 
previous studies examining eNOS protein content with aging show inconsistent results, 
with some studies showing an increase, (Goettsch et al. 2001; van der Loo et al. 2000a) 
others showing a decrease, (Barton et al. 1997a; Tanabe et al. 2003a; Woodman et al. 
2005; Csiszar et al. 2002) and others showing no change in eNOS protein content 
(Woodman et al. 2002). Sindler et al. (Sindler et al. 2009) demonstrated that 
endothelium-dependent dilation is impaired with aging in rat skeletal muscle arterioles, 
despite an increase in eNOS protein content. The discrepancy of results may reflect 
differences in the vascular bed being studied, as additional research has demonstrated 
that endothelium-dependent dilation is preserved with aging in arteries feeding 
glycolytic skeletal muscle, while in feed arteries perfusing oxidative skeletal muscles, 
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endothelium-dependent dilation is impaired with age, despite no age differences in total 
eNOS content in either glycolytic or oxidative skeletal muscle feed arteries (Woodman 
et al. 2002).  
 Another mechanism hypothesized to account for the age-related decline in NO-
mediated endothelial function is the well-documented increase in oxidative stress seen 
with aging. Scavenging of NO by pro-oxidants reduces NO bioavailability even when 
eNOS protein content and enzyme activity are unchanged. Trott et al. (Trott et al. 2011) 
have demonstrated that inhibition of a key oxidant enzyme, NAD(P)H oxidase, restored 
NO-mediated endothelial function in soleus muscle feed arteries (SFA). Furthermore, 
this same study also showed that O2
.- scavenging with TEMPOL and H2O2 scavenging 
with catalase restored NO-mediated endothelial function. Elevated content of NAD(P)H 
oxidase subunit gp91phox was also found in the aged SFA, which may explain the 
elevated oxidative stress seen with age.  
 The availability of eNOS cofactors, particularly BH4 is another potential 
mechanism that may account for the decline in endothelial function with aging. Delp et 
al. (Delp et al. 2008) have demonstrated that there is a reduction in BH4 content with age 
in soleus muscle first-order arterioles. Without BH4, eNOS becomes a pro-oxidant 
enzyme, thus reducing NO bioavailability by 1) decreasing the production of NO from 
eNOS, and 2) increasing the oxidative stress in the local environment that scavenges NO 
that is produced (Bendall et al. 2005).  
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Table 1.1: Mechanisms of Age-Related Impairments in Nitric Oxide Bioavailability 
Citation Model Age Vessel 
Vascular responses with 
age 
Mechanism Investigated 
Cernadas, 1998. Wistar  
young: 5 mo;               
old 18 mo 
aorta ↓ responsiveness to ACh, BK ↑eNOS and iNOS content  
Csiszar, 2002. Sprague-Dawley 
young: 14 
weeks;            
old: 80 weeks 
coronary 
arterioles 
↓ FID; augmented with SOD 
and Tiron supplementation 
↓eNOS mRNA, ↑iNOS mRNA expression 
Delp, 2008. Fisher 344 
young: 6 mo;               
old: 24 mo 
S1A 
↓FID; no effect of arginase 
inhibition or L-arginine; 
sepiapterin ↑ FID  
↓BH4 content  
Sindler, 2009. Fisher 344 
young: 3 mo;                     
old: 22 mo 
S1A ↓FID 
↑eNOS-derived O2- in old S1A; ↓BH4 and flow-
induced NO bioavailability with age 
Smith, 2006. 
Fisher 344 x            
Brown Norway 
young: 6 mo;                           
old: 36 mo 
aorta 
↓ endothelium-dependent, 
ACh-induced vasorelaxation 
 no change in eNOS protein content with age; 
↓membrane-bound eNOS with age; ↑ Cav1:eNOS, 
↓ Hsp90:eNOS, ↓Akt:eNOS with age 
Soucy, 2006. Wistar 
young: 3-4 
mo;                           
old: 22-24 mo 
aorta
↓ ACh-induced vasorelaxation 
; ↓shear stress induced NO 
release ; ↑ PWV  
↓ p/t - Akt ratio with age; ↓ p/t - eNOS ratio with 
age 
Spier, 2004. Fisher 344 
young: 4-7 
mo;                      
old: 24-26 mo 
S1A, 
G1A 
↓ACh- ID in S1A only 
in S1A: no age effect on eNOS mRNA but ↑eNOS 
content; in G1A: no age effect on eNOS mRNA or 
protein content 
Trott, 2013. Fisher 344 
young: 4 mo;                          
old: 24 mo 
SFA 
↓FID and ACh- ID; Akt and 
PI3K inhibition abolished age 
group differences  
 ↓ flow- and ACh-induced p-eNOS on Ser1177 
with age; PI3K inhibition abolishes age group 
differences in p-eNOS ser1177 
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Citation Model Age Vessel 
Vascular responses with 
age 
Mechanism Investigated 
van der Loo, 2000. 
Fisher 344 x            
Brown Norway 
young: 4-6 
mo;               
middle: 19 
mo;                
old: 32-35 mo 
aorta 
↓ ACh-induced vasorelaxation 
in old vs young and middle 
age; ↓ endothelium-dependent 
relaxation to A23187  
↓A23187-induced NO release with age; ↑ eNOS 
protein content and activity with age; ↑A23186 - 
stimulated O2
- release with age 
Woodman, 2002. Fisher 344 
young 4 mo;               
old: 24 mo 
SFA, 
GFA 
↓ ACh- ID in SFA only 
↓ eNOS and SOD-1 protein content with age in 
SFA only; no change in eNOS or SOD-1 mRNA 
expression with age in either SFA or GFA 
Woodman, 2003. Fisher 344 
young 4 mo;               
old: 24 mo 
SFA ↓ FID and ACh- ID  ↓ NO-mediated flow- and ACh-induced dilation 
Woodman, 2005 Fisher 344 
young 4 mo;                  
old: 24 mo 
SFA 
↓ ACh- ID; improved with 
acute flow treatment 
↓ eNOS mRNA expression with age; ↑ eNOS 
mRNA expression with age in response to flow 
treatment 
Woodman, 2007. Fisher 344 
young 4 mo;                
old: 24 mo 
SFA 
↓ FID and ACh- ID; improved 
with acute high pressure 
treatment 
pressure treatment ↑ eNOS mRNA expression in 
young but not old SFA; no change in eNOS protein 
content with pressure treatment in either old or 
young SFA 
 
          
Abbreviations: BK – bradykinin: iNOS – inducible nitric oxide synthase; FID – flow-induced dilation; SOD – superoxide dismutase; S1A – soleus first 
order arterioles; BH4 – tetrahydrobiopterin; NO – nitric oxide; PWV – pulse wave velocity; G1A – gastrocnemius first order arterioles; ACh – ID – 
acetylcholine-induced dilation; SFA - soleus feed arteries; GFA – gastrocnemius feed arteries 
Table 1.1 continued 
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Changes in post-translational mechanisms like protein:protein interactions that 
modulate eNOS activity have not been thoroughly explored in the context of aging. 
eNOS activity is regulated by a number of proteins, including Cav1, a negative regulator 
of eNOS activity (Du and Chen 2009; Smith et al. 2006; Michel et al. 1997a), and Hsp90 
and CaM, positive regulators of eNOS activity (Garcia-Cardena et al. 1998; Michel et al. 
1997a). Recent evidence from endothelial cell culture studies suggests that eNOS-
associated protein:protein interactions are altered with aging (Smith et al. 2006) which 
may explain the reduced NO bioavailability seen in aged arteries. An increase in 
oxidative stress has been shown to increase eNOS association with Cav1 as a protective 
mechanism against oxidant activity of eNOS, or eNOS uncoupling in vitro (Karuppiah et 
al. 2011). eNOS uncoupling has been demonstrated in aged skeletal muscle feed arteries 
(Sindler et al. 2009); however, whether eNOS uncoupling is a mechanism accounting for 
altered protein:protein interactions with aging remains to be determined. Additionally, to 
our knowledge, no studies have examined protein:protein interactions among eNOS and 
Hsp90 or CaM, representing an gap in the current knowledge in both the aging and 
endothelial physiology literature.  
1.8 Endothelium, nitric oxide and exercise training 
Aerobic exercise training improves endothelial function in both healthy 
individuals (Clarkson et al. 1999) and people with diseases or conditions that impair 
endothelial function (DeSouza et al. 2000; Graham and Rush 2004; Hambrecht et al. 
2000b). In several studies, this improvement has been attributed to improved NO 
bioavailability (Graham and Rush 2004; Green et al. 2004). Additionally, improvements 
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in endothelial function with exercise training have been shown in several vascular beds, 
including rat aorta (Graham and Rush 2004), rat skeletal muscle feed arteries and 
arterioles (Trott et al. 2009; Koller et al. 1995). In human studies, the brachial artery 
(Graham and Rush 2004) and coronary arteries (Hambrecht et al. 2000b) have 
demonstrated improvements in endothelial function with exercise training. These studies 
demonstrate a systemic effect of endurance exercise training on endothelial function; 
however, the mechanism(s) accounting for this improvement is not fully understood. 
Aerobic exercise results in numerous changes within the cardiovascular system that may 
modulate endothelial function both acutely and chronically. It is likely that these 
endothelial adaptations to aerobic exercise training confer much of the protective 
cardiovascular benefits of exercise. 
During acute bouts of exercise, the role NO-mediated endothelial function in 
mediating exercise hyperemia in exercising muscle remains unclear. Methodological 
inconsistencies in studies examining NO-mediated endothelium-dependent vasodilation 
in exercising skeletal muscle make extrapolating the conclusions from these studies 
difficult. For example, Wilson et al. (1993) demonstrated that pharmacological inhibition 
of eNOS immediately prior to exercise did not significantly decrease limb muscle blood 
flow with exercise. In contrast, Dyke et al. (1995) showed that eNOS inhibition during 
skeletal muscle contractions attenuated blood flow to the exercising limb. However, in 
this same study NO inhibition blunted limb blood flow by approximately the same 
magnitude at rest as during exercise. This may mean that NO helps maintain vascular 
tone both at rest and during exercise, but it may not be solely responsible for the increase 
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in blood flow with exercise. Following up on these studies, Schrage et al. (Schrage et al. 
2004) showed that inhibition of eNOS and PGI2 during exercise reduced hyperemia in 
the exercising limb, although the contribution of PGI2 to forearm hyperemia was less 
than that of NO. Collectively, these studies suggest that NO contributes to exercise 
hyperemia in contracting muscles; however, there may be redundant mechanisms 
controlling this phenomenon. Therefore, NO may contribute but may not be obligatory 
to the increase in skeletal muscle blood flow during exercise in young, healthy subjects. 
Chronic endurance exercise training improves NO-mediated endothelial function 
at rest, which improves the maintenance of vascular homeostasis and importantly, 
cardiovascular disease risk. An early study by Sessa et al. (Sessa et al. 1994) showed that 
eNOS gene expression and NO production are upregulated in the coronary arteries of 
exercise-trained dogs, and hypothesized that the mechanism accounting for this was the 
increase in shear stress during a single bout of exercise. Shear stress across the luminal 
surface of endothelial cells has also been identified as a primary stimulus that initiates 
adaptations in the endothelium resulting in an increased NO bioavailability with regular 
aerobic exercise in humans (Tinken et al. 2009; Tinken et al. 2010). Chronic intermittent 
elevations in shear stress with exercise training initiates many adaptations that improve 
endothelial function long-term.   
Intermittent increases in intraluminal pressure during exercise may also confer 
benefits on endothelial function. Woodman et al. (Woodman et al. 2007) tested the 
effects of short-term increases in intraluminal pressure, mimicking the increase in 
intraluminal pressure during an acute bout of exercise, on NO-mediated endothelial 
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function in young and old SFA. Interestingly, they found that while acute treatment with 
elevated pressure improved NO-mediated, flow-induced vasodilation in old SFA, the 
improvement in endothelial function was not accompanied by an increase in eNOS 
mRNA expression. However, in young SFA, short-term pressure treatment increased 
both eNOS and SOD-1 mRNA expression, but had no effect on NO-mediated 
endothelial function. Thus, it appears that short-term increases in intraluminal pressure 
may improve NO bioavailability in old SFA; however, the mechanism accounting for the 
improvements in NO-mediated endothelial function in old SFA with short-term 
increases in intraluminal pressure remains to be determined.  
Chronic endurance exercise training also appears to improve the cellular 
signaling mechanisms responsible for maintaining NO bioavailability. One potential 
beneficial effect of endurance exercise training is the reduction in oxidative stress, which 
may be due to an upregulation of antioxidant enzymes like SOD-1 (Rush et al. 2003) or 
downregulation of oxidant enzymes like NAD(P)H subunit gp91phox (Graham and 
Rush 2004). This in turn reduces the scavenging of NO by ROS, increasing its 
bioavailability and improving NO-mediated endothelial function.  
Post-translational mechanisms regulating eNOS may also be altered with 
exercise training, resulting in improved NO-mediated endothelial function. Hambrecht et 
al. (Hambrecht et al. 2003) found improved NO-mediated endothelial function 
accompanied by increased eNOS phosphorylation on Ser1177 in coronary arteries from 
individuals with coronary artery disease who were exercise trained for 4 weeks. The 
increase in eNOS phosphorylation on Ser1177 was correlated to an increase Akt 
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phosphorylation, suggesting that exercise training favorably alters Akt pathway 
signaling in the endothelium resulting in improved NO synthesis via eNOS.   
In vitro research has demonstrated an important role of shear stress in regulating 
Cav1 interactions with eNOS (Rizzo et al. 1998b), suggesting that protein:protein 
interactions may be regulated by the mechanical stimuli associated with exercise, and 
may thus be altered by exercise training. There is also evidence suggesting that exercise 
training increases the interaction between Hsp90 and eNOS (Harris et al. 2008), 
although this was found in the soleus muscle tissue, not vascular endothelial cells. 
However, the possibility remains that the same or similar mechanisms that increase 
Hsp90:eNOS interaction in skeletal muscle may also alter Hsp90:eNOS interaction in 
the endothelium. Regardless, more research is needed to thoroughly investigate this 
mechanism of post-translational regulation of eNOS with exercise training. 
Finally, endurance exercise appears to attenuate or reverse the negative effects of 
aging on endothelial function (Trott et al. 2009; Spier et al. 2004; Fitzgerald et al. 1997; 
DeSouza et al. 2000). In a cross-sectional study, Master’s athletes (64.7 ± 1.4 y/o) who 
had engaged in lifelong aerobic exercise had greater endothelium-dependent dilation in 
the brachial artery compared to age-matched, sedentary individuals. In a separate study 
(Taddei et al. 2000), endurance-trained elderly men (66.4 ± 6.1 y/o) had endothelium-
dependent forearm vasodilator responses greater than their sedentary counterparts (62.9 
± 6.1 y/o) and similar to young sedentary men (26.9 ± 2.3 y/o). Additionally, previously 
sedentary older adults who started an endurance exercise program improved brachial 
artery endothelial function compared to their counterparts who remained sedentary, and 
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restored endothelial function to levels similar to the young sedentary men (DeSouza et 
al. 2000). The beneficial effects of exercise training on NO-mediated endothelial 
function have been demonstrated in animal models of aging as well (Spier et al. 2004; 
Trott et al. 2009; Hashimoto 1990). Results from these exercise training studies in 
animal models further support the beneficial effects of endurance exercise training on 
endothelial function with aging.  
1.9 Regional heterogeneity of endothelial cell aging 
In the arterial tree, there are key anatomical differences between the large conduit 
arteries, and smaller resistance-sized arteries and arterioles. These anatomical 
differences reflect the different functional requirements of the different types of arteries. 
In large conduit arteries like the aorta and brachial, iliac, and femoral arteries, there is a 
thick medial elastic layer allowing the high pressure generated by the heart to be 
absorbed and stored as potential energy in what is described as a “Windkessel” effect. 
The recoil of the elastic tissue in conduit arteries keeps blood flowing through the 
cardiovascular system during diastole of the heart. In humans, conduit artery endothelial 
function can be assessed using ultrasonography using brachial artery flow-mediated 
dilation (Corretti et al. 2002). Endothelial function in conduit arteries declines with age, 
and is associated with the development of atherosclerosis and the development of 
cardiovascular diseases (Celermajer et al. 1994a). Along with the decline in endothelial 
function with age, there is also a loss of arterial compliance, and an increase in arterial 
stiffness, exacerbating the risk of developing cardiovascular diseases and hypertension 
(Tanaka et al. 2000). A cross-sectional study of individuals with and without coronary 
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heart disease established a significant positive correlation between NO-mediated 
endothelial function and conduit artery stiffness (Nigam et al. 2003). However, no causal 
link between endothelial function and arterial stiffness was established in this study. 
Endothelium-derived NO contributes to the maintenance of basal tone in conduit vessels 
(Fok et al. 2012; Stewart et al. 2003; Fitch et al. 2001), and NO inhibition increases 
measures of arterial stiffness during changes in blood flow (Bellien et al. 2010) in 
healthy adults.  
In a study conducted by Soucy et al. (2006) a potential mechanism linking 
endothelium-derived NO and aortic stiffness in aging was explored.  In this study, old 
rats had impaired NO-mediated endothelial function, reduced NO bioavailability, and 
increased pulse-wave velocity (PWV; a measure of aortic stiffness) compared to young 
rats. Furthermore, eNOS inhibition impaired aortic stiffness and endothelial function in 
the young, while exogenous NO improved aortic stiffness and endothelial function in the 
old aortas. Finally, this study also identified impaired PI3K/Akt signaling in the old 
aortas as one potential mechanism for the increase in aortic stiffness with age. These 
studies highlight the role of endothelium-derived NO in the function of conduit arteries 
and establish a link between the aging process and impaired endothelial function in 
conduit arteries. Despite the documented link between endothelium-derived NO and the 
maintenance of vascular tone, the mechanisms accounting for the age-related loss of 
NO-mediated endothelial function in conduit arteries remain to be determined. 
In contrast to the large conduit arteries, resistance sized arteries and arterioles 
have multiple layers of smooth muscle in the medial layer regulating the diameter of the 
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vessel and allowing for fine tuning of regional blood flow to precisely meet oxygen and 
nutrient demand with blood supply. While endothelial dysfunction in large elastic 
conduit arteries is linked to the development of cardiovascular diseases, endothelial 
dysfunction in the smaller, resistance sized arteries and arterioles is linked to altered 
blood flow in a variety of tissue (Prisby et al. 2007; Zeiher et al. 1991a). Interestingly, 
aging has been shown to impair skeletal muscle blood flow with moderate intensity 
exercise to oxidative skeletal muscles, whereas blood flow is elevated in arteries 
perfusing glycolytic skeletal muscles (Musch et al. 2004). The altered blood flow pattern 
between oxidative and glycolytic skeletal muscle is hypothesized to be one mechanism 
accounting for the age-related decline in exercise capacity (Irion et al. 1987). Research 
by Woodman et al. (Woodman et al. 2002) also demonstrated muscle fiber-type 
differences in NO-mediated endothelial dysfunction, showing that endothelial function is 
maintained with age in gastrocnemius feed arteries (GFA), while endothelial function is 
impaired in SFA. This finding is supported by a later study by Hirai et al. (Hirai et al. 
2011) who showed that both vascular conductance (an indicator of blood flow) and NO-
dependent endothelial function is impaired with age in SFA compared to GFA.  
Together, these results suggest that aging exerts differential effects on endothelial 
phenotype in resistance arteries from glycolytic vs. oxidative skeletal muscles that 
account for the regional differences in blood flow and endothelial function.  
Additionally, there appears to be heterogeneity in the effects of aging on the 
arterioles downstream of the feed arteries in both oxidative and glycolytic muscles. 
Muller-Delp et al. (Muller-Delp et al. 2002) found that while flow-induced, NO-
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mediated vasodilation was impaired with age in both soleus and gastrocnemius first 
order arterioles, ACh-induced vasodilation was only impaired in first order arterioles 
from the soleus muscle. This study also demonstrates regional heterogeneity within the 
rat hindlimb with respect to endothelial phenotype and function with aging.  However, 
the mechanisms accounting for the differences in alterations in endothelial function 
between oxidative and glycolytic resistance-sized vessels are not fully understood.  
The mechanisms underlying the age-associated impairment in NO-mediated 
endothelial function remain to be fully elucidated. Furthermore, the apparent regional 
heterogeneity of the effects of age on endothelial function adds an additional layer of 
complexity to the understanding of these mechanisms. It is likely that the decline in NO-
mediated endothelial function with aging is related to disparate changes in the local 
environment between conduit and resistance arteries, and between arteries and arterioles 
perfusing oxidative vs. glycolytic skeletal muscles. As a result, it is important to 
distinguish the various mechanisms accounting for the age-related decline in endothelial 
function in different vascular beds so that appropriate countermeasures can be developed 
that target specific mechanisms of aging in specific vessels to achieve individualized 
outcomes. 
1.10 Hypotheses and purpose 
To our knowledge, this is the first set of studies examining the effects of age and 
aerobic exercise training on protein:protein interactions regulating eNOS activity in aged 
arteries and arterioles throughout the arterial tree. Additionally, these studies help 
establish a phenotype of protein:protein interactions among eNOS and its regulatory 
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proteins in endothelium of young and old arteries of both conduit and resistance-sized 
vessels. The hypotheses of the following studies are: 1) aging results in an impairment of 
NO-mediated endothelium-dependent vasorelaxation in the rat aorta; 2) the impaired 
endothelium-dependent vasorelaxation in aged rat aortas is associated with alterations in 
protein:protein interactions between eNOS and its regulatory proteins (specifically, 
Cav1, Hsp90, and CaM); 3) endurance exercise training improves or restores NO-
mediated vasorelaxation in aged aortas by reversing the detrimental effects of aging on 
protein:protein interactions between eNOS and its regulatory proteins; 4) the endothelial 
phenotype of protein:protein interactions between eNOS and its regulatory proteins will 
not be uniform throughout the arterial tree, from the aorta through low-order skeletal 
muscle arterioles; 5) aging will have a heterogeneous effect on the endothelial  
phenotype of protein:protein interactions between eNOS and its regulatory proteins 
throughout the arterial tree, from the aorta through low-order skeletal muscle arterioles; 
and finally, 6) there will be a difference in endothelial phenotype of protein:protein 
interactions between eNOS and its regulatory proteins with age and skeletal muscle fiber 
type between soleus muscle and gastrocnemius muscle feed arteries and arterioles. 
The purpose of the research presented in this dissertation is to set the groundwork 
for a comprehensive investigation of a poorly understood mechanism of impaired 
endothelial function with age. Consequently, it is expected that the impact of this 
research to be a step forward in understanding of the effects of aging and the beneficial 
effects of exercise on NO-mediated vascular function throughout the arterial tree. This 
contribution will be significant because this project will focus on an unexplored 
 
29 
 
mechanism of age-related endothelial dysfunction that may be of significant interest in 
the development of therapeutic strategies to reduce the impact of cardiovascular diseases 
prevalent in older individuals. Furthermore, identifying a mechanism of endothelial 
dysfunction that is also a site of adaptation to aerobic exercise may lead to the 
development of cost-effective strategies for prevention and management of age-related 
endothelial dysfunction and consequent cardiovascular diseases, thus improving the 
quality of life for older adults.  
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CHAPTER II 
EFFECT OF AGING ON PROTEIN:PROTEIN INTERACTIONS AMONG eNOS 
AND KEY REGULATORY PROTEINS THROUGHOUT THE ARTERIAL 
NETWORK 
2.1 Introduction 
An age-related decline in nitric oxide (NO)-mediated endothelial function has 
been demonstrated in numerous vascular beds, resulting in an increased risk of 
developing cardiovascular diseases (Celermajer et al. 1994a). Due to the heterogeneity 
of structure and function throughout the arterial tree, the effects of aging on NO-
mediated endothelial function are similarly varied. Regional heterogeneity in endothelial 
function with age has been demonstrated in skeletal muscle feed arteries from oxidative 
versus glycolytic skeletal muscle (Woodman et al. 2002).  In this study, aging resulted in 
an impaired endothelium-dependent, NO-mediated dilation in soleus feed arteries (SFA), 
while endothelial function in gastrocnemius feed arteries was preserved. Resistance-
sized arteries and arterioles are sensitive to metabolic regulation of vascular tone, and it 
is possible that the metabolic milieu of the glycolytic portion of the gastrocnemius 
versus the oxidative soleus muscle accounts for difference in the effect of age on NO-
mediated endothelial function. The disparate effect of aging on endothelial function in 
glycolytic versus oxidative skeletal muscle feed arteries is consistent with alterations in 
skeletal muscle blood flow to glycolytic and oxidative skeletal muscles with age. As has 
been previously shown by Musch et al. (2004), there is a reduced ability to increase 
blood flow to oxidative skeletal muscle and an enhanced blood flow to glycolytic 
 
31 
 
skeletal muscle during exercise with age. Thus, it is likely that differences in blood flow 
patterns and the local environment during exercise contribute to regional differences in 
vascular endothelial function. Furthermore, in some large arteries like the femoral artery, 
NO-mediated endothelial function is also preserved with age, while endothelial function 
in the aorta declines (Barton et al. 1997c). The authors of this study attribute these 
differences to regional differences in pulse pressure stimulus between the aorta and 
femoral artery. These studies suggest the possibility that the mechanisms accounting for 
the decline in NO-mediated endothelial function with age may vary throughout the 
vascular tree.  
Age-related changes in post-translational mechanisms regulating eNOS enzyme 
activity are an intriguing candidate as a potential mechanism accounting for the impaired 
NO bioavailability with age. One post-translational change that may impair NO-
mediated endothelial function with age is alterations in protein:protein interactions 
among endothelial nitric oxide synthase (eNOS) and its key regulatory proteins, 
caveolin-1 (Cav1), and calmodulin (CaM). Cav1 is a negative regulator of eNOS activity 
(Michel et al. 1997a), so that an increase in Cav1 binding to eNOS may limit NO 
bioavailability and result in impaired NO-mediated endothelial function. In contrast, 
CaM is a positive regulator of eNOS activity (Michel et al. 1997a; Garcia-Cardena et al. 
1998), thus potentially increasing enzyme activity and NO bioavailability when bound to 
eNOS.   Work by Smith et al. (2006) demonstrated reduced Cav1:eNOS interaction with 
age in aortas; however, the significance of changes in protein:protein interactions with 
age throughout the vascular tree remains unknown.  
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The purpose of the present study was to: 1) characterize the phenotype of eNOS-
associated protein:protein interactions throughout the vascular tree, from the abdominal 
aorta to third order skeletal muscle arterioles; 2) determine the effect of aging on the 
phenotype of eNOS-associated protein:protein interactions throughout the vascular tree; 
and 3) compare the effect of aging on the phenotype of eNOS-associated protein:protein 
interactions between the feed arteries and arterioles in glycolytic versus oxidative 
skeletal muscles.  
2.2 Methods 
2.2.1 Animals 
 Prior to the start of this study, approval for the use of animals was obtained from 
the University of Missouri and Texas A&M University’s Institutional Animal Care and 
Use Committees. Young (4 mo, n = 9) and old (24 mo, n = 9) male Fischer 344 rats were 
obtained from a commercial dealer (Harlan Sprague-Dawley, Indianapolis, IN) and 
housed at the University of Missouri College of Veterinary Medicine’s Animal Care 
Facility. All rats were housed under a 12:12-h light-dark cycle and food and water were 
provided ad libitum. The rats were examined daily by the Animal Care Facility 
veterinarians or staff.  
2.2.2 Isolation of vascular tissue 
 Prior to the removal of vascular tissue, rats were anesthetized with an 
intraperitoneal injection of pentobarbital sodium (50 – 60 mg/kg body wt, ip). The 
thoracic and abdominal cavities were exposed and sections of the abdominal aorta, iliac, 
and femoral arteries were dissected out, placed in 0.7 uL microcentrifuge tubes, snap 
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frozen, and stored at -80°C for subsequent co-immunoprecipitation and immunoblot 
analysis.  
To collect the skeletal muscle feed arteries and arterioles, the 
gastrocnemius/soleus skeletal muscle complex was removed from the hindlimbs and 
placed in cold (4°C) MOPS buffered physiological saline solution (PSS), containing (in 
mM): 145.0 NaCl, 4.7 KCl, 2.0 CaCl2 , 1.17 MgSO4, 1.2 NaH2PO4, 5.0 glucose, 2.0 
pyruvate, 0.02 EDTA and 25.0 MOPS (pH 7.4). The gastrocnemius/soleus complex was 
then transferred to a Lucite chamber containing MOPS-PSS for dissection of skeletal 
muscle feed arteries and arterioles. The soleus muscle feed artery (SFA), first order 
(S1A), second order (S2A), and third order (S3A) arterioles were each dissected out and 
placed in separate 0.7 mL microcentrifuge tubes, snap frozen, and stored at -80°C for 
subsequent co-immunoprecipitation and immunoblot analysis. The gastrocnemius 
muscle was separated into the white (glycolytic) portion and red (oxidative) portions. 
The gastrocnemius feed artery (GFA) and first order arteriole (G1A) were identified, 
along with the second and third order arterioles of the red portion (RG2A, RG3A, 
respectively) and second and third order arterioles of the white portion (WG2A, WG3A, 
respectively). These vessels were dissected out and also placed in separate 0.7 mL 
microcentrifuge tubes, snap frozen, and stored at -80°C for subsequent co-
immunoprecipitation and immunoblot analysis.  
2.2.3 Immunoprecipitation 
 The aorta, iliac arteries, and femoral arteries were homogenized using a mortar 
and pestle, then transferred to a microcentrifuge tube with a lysis buffer containing (in 
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mM): 60.0 octyl-β-d-glucopyranoside (Sigma-Aldrich, O8001), 150.0 NaCl, 20.0 Tris 
base, 1% protease inhibitor cocktail (EMD Millipore, 20-201), 1% phosphatase inhibitor 
cocktail (Sigma-Aldrich, P0044). These vessel segments were further homogenized 
using repeated freeze-thaw cycles with brief sonication. For the smaller vessels (SFA, 
GFA, S1A, G1A, RG2A, RG3A, WG2A, WG3A), lysis buffer was added to the 
microcentrifuge tubes for homogenization using repeated freeze-thaw cycles. 8-10 
arterioles were pooled to ensure adequate protein concentration for each group. To 
collect the soluble proteins from all vessels, the homogenates were centrifuged for 10 
min at 12,000Xg at 4°C and the supernatant collected and used for co-
immunoprecipitation.  
2.2.3.1 Co-Immunoprecipitation of arteries 
For co-immunoprecipitation of the aorta and arteries, 20µL of Protein G/A 
agarose suspension was added to the lysate and incubated at 4°C for 1 hour under gentle 
rotary agitation. After centrifugation at 12,000XG for 1 min, the supernatant was 
collected. 1 µg of polyclonal eNOS antibody was added to the lysate and incubated for 4 
hours at 4°C under gentle rotary agitation.  15µL of Protein G/A agarose suspension was 
then added to the lysate and incubated for 1 hour at 4°C under gentle rotary agitation. 
The eNOS protein complex was then eluted from the lysate, washed three times and 
stored at -80°C in Laemmli buffer for immunoblotting. 
2.2.3.2 Co-Immunoprecipitation of arterioles 
For co-immunoprecipitation of G1A, S1A, RG2A, RG3A, WG2A, and WG3A, 1 
μg of polyclonal eNOS antibody was added to the lysate and incubated overnight at 4°C 
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under gentle rotary agitation. 15µL of Protein G/A agarose suspension was then added to 
the lysate and incubated for 1 hour at 4°C under gentle rotary agitation. The eNOS 
protein complex was then eluted from the lysate, washed twice and stored at  -80°C in 
Laemmli buffer for immunoblotting. 
2.2.4 Quantification of Cav1:eNOS and CaM:eNOS interactions 
 Relative differences in eNOS, Cav1, and CaM content between age groups were 
assessed in all vessels using immunoblot analysis as described in detail previously 
(Jasperse and Laughlin 1999). eNOS, Cav1 and CaM protein content were evaluated 
using monoclonal antibodies (eNOS and CaM, 1:1250; Cav1, 1:2500). Immunoblots 
were evaluated using enhanced chemiluminescence (ECL, Amersham) and densitometry 
using LAS-4000 Luminescent Image Analyzer and Multi-Gauge Image Analysis 
Software (FUJIFILM Medical Systems). 
2.2.5 Statistical analysis 
 All values are presented as mean ± SE. Two-way ANOVA was used to 
determine age- and vessel-group differences in protein:protein interactions. One-way 
ANOVA was used to determine vessel-group differences in protein:protein interactions 
within each age group individually. Statistical significance was set at the P ≤ 0.05 
probability level. Due to the limited amount of arteriolar tissue available for biochemical 
analysis, some of these groups were excluded from statistical analysis due to small n-
size, although the means are displayed in the graphs below.   
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2.3 Results 
2.3.1 Total eNOS protein content 
 Total eNOS protein content in all vessels is shown in Figure 2.1 Total eNOS 
protein content was not significantly altered with age in any of the vessels studied. There 
were no significant differences between any vessels in total eNOS protein content. 
2.3.2 Cav1:eNOS interactions 
 Cav1:eNOS interaction in all vessels is shown in Figure 2.2. Cav1:eNOS 
interaction was not significantly altered with age in any of the vessels studied. There 
were no significant differences between any vessels in Cav1:eNOS interaction. 
2.3.3 CaM:eNOS interactions 
 CaM:eNOS interaction in all vessels is shown in Figure 2.3. CaM:eNOS 
interaction was not altered with age. However, among young vessels, CaM:eNOS 
interaction was significantly greater in SFA compared to the aorta, iliac, femoral, and 
gastrocnemius feed artery, WG3A, and S2A. 
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  Figure 2.1. Total eNOS protein content in arteries and arterioles.  Values are 
means ± SE; No significant differences between groups. Values with no 
standard error bars have n ≤ 2 per group. 
Figure 2.1 
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  Figure 2.2. Vascular heterogeneity of Cav1 association with eNOS.  Antibodies 
against eNOS were used to immunoprecipitate eNOS protein.  The 
immunoprecipitates were analyzed for associated Cav-1 by immunoblot.  No 
significant differences between groups. Values with no standard error bars have n ≤ 
2 per group. 
Figure 2.2 
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Figure 2.3. Vascular heterogeneity of CaM association with eNOS.  Antibodies 
against eNOS were used to immunoprecipitate eNOS protein.  The 
immunoprecipitates were analyzed for associated CaM by immunoblot.  Values are 
means ± SE. n = 3-6/group. Values with no standard error bars have n ≤ 2 per group. 
??ignificantly different from young SFA, p ≤ 0.05. 
Figure 2.3 
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2.4 Discussion 
 The primary findings from this study are as follows: 1) total eNOS protein 
content is not significantly altered with age throughout the arterial network; 2) 
CaM:eNOS interaction in young animals is heterogeneous throughout the arterial 
network; and 3) aging has no significant effect on Cav1:eNOS and CaM:eNOS 
interactions throughout the arterial network.  
 These findings emphasize the heterogeneous phenotype of the arteries and 
arterioles, especially from young animals, examined in this study. This heterogeneity 
exists primarily between the young SFA and large arteries (aorta, iliac, and femoral 
artery), muscular arteries (GFA), and arterioles from both oxidative and glycolytic 
skeletal muscles (WG3A, S2A). Even arterioles within an isolated skeletal muscle 
display a heterogeneous protein:protein interaction phenotype. These differences are 
likely due, at least in part, to the different anatomical structures, blood flow patterns, and 
metabolic milieu between oxidative and glycolytic skeletal muscles.  
 The effect that aging has on protein:protein interactions throughout the arterial 
tree are also varied. This likely reflects the tissue-specific effects of aging on blood flow 
patterns and the local metabolic environment. It is also possible that the age-related 
alterations in protein:protein interactions may confer some benefit in certain vessels that 
do not demonstrate age-related endothelial dysfunction. For example, Cav1 sequestering 
of eNOS may prevent eNOS from becoming a pro-oxidant enzyme in aged vessels that 
do not demonstrate impaired NO-mediated endothelial function (Karuppiah et al. 2011).  
Thus, it is conceivable that aging results in eNOS-associated protein:protein interactions 
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that are a mechanism to compensate for impaired NO bioavailability. However, the 
impact this increase in Cav1:eNOS interaction has on NO-mediated endothelial function 
remains to be determined, as no significant differences in Cav1:eNOS interactions were 
detected. However, it is possible that Cav1:eNOS interactions may be altered with age 
by mechanisms that would not be detected using co-immunoprecipitation and 
immunoblotting techniques (Aoki et al. 1999).  
 Interestingly, the CaM:eNOS interaction was only significantly affected by 
vessel heterogeneity in young animals when compared to young SFA. This may reflect 
heterogeneity of eNOS regulation by CaM throughout the arterial tree. Traditionally 
Cav1 and CaM have been thought to reciprocally regulate eNOS activity (Michel et al. 
1997b; Michel et al. 1997c), while findings from the present study suggest that while 
this may be true, the protein:protein interactions do not show a pattern of reciprocal 
regulation (Figuress. 2.2, 2.3).  
 Within the skeletal muscles of the hindlimb, the CaM:eNOS interaction was 
significantly higher in the young SFA compared to GFA and arterioles from both SFA 
and GFA. This may reflect the high level of control the SFA exerts over regulating blood 
flow to the primarily oxidative soleus muscle, both and rest and during aerobic exercise. 
However, further studies are needed to confirm these results and determine the role of 
CaM:eNOS interaction in NO-mediated endothelial function. 
 Results from this study demonstrate the heterogeneous phenotype of CaM:eNOS 
throughout the arterial network. The non-uniform effect of arterial structure and function 
on protein:protein interactions may contribute to the heterogeneous phenotype of 
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CaM:eNOS interaction. However, this study suggests that neither Cav1:eNOS nor 
CaM:eNOS interactions are altered with aging throughout the arterial network.  
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CHAPTER III 
EFFECT OF AGE AND EXERCISE TRAINING ON PROTEIN:PROTEIN 
INTERACTIONS AMONG eNOS AND ITS REGULATORY PROTEINS IN RAT 
AORTAS* 
3.1 Introduction 
 Aging is an independent risk factor for cardiovascular disease, as is impaired 
endothelial function (Celermajer et al. 1994b). Previous studies have demonstrated an 
age-related decline in endothelium-mediated vasorelaxation in aortas (Smith et al. 2006; 
Delp et al. 1995); however, the mechanism(s) accounting for the age-related decline in 
nitric oxide (NO)-mediated endothelial function in aged arteries is not fully understood.  
NO bioavailability is critical for maintaining normal endothelial function, and numerous 
studies have demonstrated reduced NO bioavailability in various vascular beds in older 
humans and aged animals (Muller-Delp et al. 2002b; Cernadas et al. 1998; Kang et al. 
2009b; Celermajer et al. 1994b; van der Loo et al. 2000b; Trott et al. 2013; Trott et al. 
2011; Woodman et al. 2003). Endothelial nitric oxide synthase (eNOS) is the enzyme 
responsible for generating NO in endothelial cells. In conduit arteries, age-related 
increases in eNOS content have been documented (van der Loo et al. 2000b; Cernadas et 
al. 1998); however, this finding has not been consistently reported by all investigators 
(Barton et al. 1997b). Post-translational modifications of the eNOS protein, independent 
of changes in eNOS protein content, may play a role in regulating eNOS activity and NO 
bioavailability in aged arteries (Smith and Hagen 2003; Michel et al. 1997b). 
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∗ Reprinted with permission from “Effect of age and exercise training on protein:protein interactions 
among eNOS and its regulatory proteins in rat aortas” by MJ Luttrell, JW Seawright, E Wilson, CR 
Woodman, 2013. European Journal of Applied Physiology, 113, 2761-2768, Copyright [2013] by 
Springer-Verlag Berlin Heidelberg. 
                                                            
Age-related changes in post-translational mechanisms like protein:protein 
interactions that modulate eNOS activity have not been thoroughly explored. eNOS 
activity is regulated by a number of proteins, including caveolin-1 (Cav1), a negative 
regulator of eNOS activity (Du and Chen 2009; Smith et al. 2006; Michel et al. 1997b), 
as well as heat shock protein 90 (Hsp90) and calmodulin (CaM), positive regulators of 
eNOS activity (Garcia-Cardena et al. 1998; Michel et al. 1997b). Evidence from in vitro 
studies suggests that eNOS interaction with Cav1 is increased with aging (Smith et al. 
2006; Yoon et al. 2010) which may explain the reduced NO bioavailability seen in aged 
arteries. Additionally, there is evidence suggesting that aging reduces the interaction 
between eNOS and Hsp90 (Smith et al. 2006). Collectively, these studies identify key 
regulatory proteins of eNOS that may be of interest in elucidating a potential mechanism 
accounting for the impaired NO-mediated endothelial function with aging. 
Aerobic exercise training has been shown to attenuate or reverse the detrimental 
effects of aging on endothelium-dependent dilation (DeSouza et al. 2000; Spier et al. 
2004; Trott et al. 2009); however, the mechanism(s) accounting for the beneficial effect 
of exercise training is not fully understood. Shear stress has been identified as an 
important stimulus that initiates adaptations in the endothelium resulting in an increased 
NO bioavailability in aged vessels with aerobic exercise (Davis et al. 2001; Fisslthaler et 
al. 2000). Previous research has demonstrated that shear stress regulates Cav1 
interactions with eNOS (Rizzo et al. 1998a), suggesting that Cav1:eNOS interaction may 
be a site of therapeutic interest in the prevention and treatment of cardiovascular 
diseases. Furthermore, endurance exercise training has been shown to enhance Hsp90 
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expression in soleus skeletal muscle tissue (Harris et al. 2008), which can potentially 
enhance NO bioavailability. When bound to eNOS, Hsp90 enhances eNOS enzyme 
activity and NO production. Importantly, the interactive effects of aging and exercise 
training on protein:protein interactions between Hsp90 and eNOS in arteries are 
unknown. CaM, a calcium-sensitive protein that displaces Cav1 from eNOS also 
facilitates NO production when bound to eNOS (Busse and Mülsch 1990). To date, little 
is known about the effects of age and exercise training on CaM and Cav1 protein content 
and its interaction with eNOS. 
The purpose of the present study was to test the hypothesis that impaired 
endothelium-dependent relaxation in aged aorta is due to alterations in protein:protein 
interactions between eNOS and its regulatory proteins resulting in impaired NO-
mediated relaxation. In addition, we hypothesized that endurance exercise training 
improves or restores NO-mediated vasorelaxation in aged aorta by reversing the 
detrimental effects of aging on protein:protein interaction between eNOS and its 
regulatory proteins. 
3.2 Methods 
3.2.1 Animals 
 Before the initiation of this study, approval was received from the University of 
Missouri and Texas A&M University Institutional Animal Care and Use Committees.  
Young (2 mo) and old (22 mo) male Fischer 344 rats were obtained from a commercial 
dealer (Harlan Sprague-Dawley, Indianapolis, IN) and housed at the University of 
Missouri College of Veterinary Medicine’s Animal Care Facility or the Texas A&M 
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University Comparative Medicine Program Facility. The rats used in the present study 
were a subgroup of rats used in a previously published study of the effects of training on 
soleus muscle resistance arteries (Trott et al. 2009) . All rats were housed under a 12:12-
h light-dark cycle and food and water were provided ad libitum. The rats were examined 
daily by the Animal Care Facility veterinarians. Fischer 344 rats were chosen for these 
experiments because of the absence of atherosclerosis and hypertension with age in this 
animal model (Lakatta 1995). Upon arrival, young and old rats were randomly assigned 
to either the sedentary (Sed) or exercise trained group (Ex) for a total of four groups of 
rats: 1) young Sed (n = 10), 2) young Ex (n = 10), 3) old Sed (n = 10), and 4) old Ex (n = 
10).  
3.2.2 Training protocol 
 The exercise training protocol used in this study has been described previously 
(Spier et al. 2004; Trott et al. 2009).  In brief, rats were familiarized with running on a 
motorized treadmill and randomly assigned to an Ex or Sed group for 10-12 weeks. Rats 
in the Ex group ran 60 min/day, 5 days/week, at 15m/min (15° incline).  Rats in the Sed 
group were restricted to their cages and did not exercise. To determine the efficacy of 
the endurance exercise training protocol, citrate synthase activity was measured in the 
vastus lateralis muscle (Srere 1969). 
3.2.3 Isolation of aortas 
 Prior to removal of the aortas, rats were anesthetized with an intraperitoneal 
injection of pentobarbital sodium (50-60 mg/kg body wt, ip). The thoracic and 
abdominal cavities were exposed and the abdominal aorta was dissected out and placed 
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in cold (4°C) MOPS buffered physiological saline solution (PSS), containing (in mM) 
145.0 NaCl, 4.7 KCl, 2.0 CaCl2 , 1.17 MgSO4, 1.2 NaH2PO4, 5.0 glucose, 2.0 pyruvate, 
0.02 EDTA and 25.0 MOPS (pH 7.4). The aorta was then transferred to a Lucite 
chamber containing MOPS-PSS for removal of adipose and connective tissue, and 
sectioned into rings approximately 2 millimeters in axial length. Aortic rings used for 
functional analysis of vasoreactivity were mounted on a wire myograph. The remaining 
aortic segments were placed in 0.7 mL microcentrifuge tubes, snap frozen, and stored at 
-80°C for subsequent co-immunoprecipitation and immunoblot analysis. 
3.2.4 Determination of vasorelaxation responses 
 The protocol used to determine aortic vasorelaxation responses has been 
described previously in detail (Delp et al. 1993). Briefly, aortic rings were mounted on 
two stainless steel wires, one attached to a force transducer, and the other attached to a 
micrometer microdrive. The aortic ring and myograph apparatus was placed in a Krebs 
bicarbonate buffer solution equilibrated at 37°C with 95% O2-5% CO2. Isometric tension 
was continuously monitored. Aortic rings were preconstricted with norepinephrine (10-
7M) and endothelium-dependent vasorelaxation responses were assessed in response to 
ACh stimulation by adding cumulative doses over the range of 10-10 – 10-4 M in half log 
increments as described previously (Delp et al. 1995). To determine the role of NO, 
ACh-induced vasorelaxation responses were assessed in the absence or presence of L-
NG-nitroarginine methyl ester (L-NAME, 300μM) to inhibit NOS. Endothelium-
independent relaxation responses to sodium nitroprusside (SNP) were measured by 
adding cumulative doses over the range of 10-10 – 10-4 M in half log increments. 
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3.2.5 Immunoprecipitation 
 To assess  protein:protein interactions among eNOS and its regulatory proteins in 
aortas from young and old Sed and Ex rats, frozen aortic segments were homogenized 
using a mortar and pestle, then transferred to a microcentrifuge tube  with a lysis buffer 
containing (in mM): 60.0 octyl-β-d-glucopyranoside (Sigma-Aldrich, O8001), 150.0 
NaCl, 20.0Tris base, 1% protease inhibitor cocktail (EMD Millipore, 20-201), 1% 
phosphatase inhibitor cocktail (Sigma-Aldrich, P0044). The aortic segments were further 
homogenized using repeated freeze-thaw cycles with brief sonication. To collect the 
soluble proteins, the homogenate was centrifuged for 10 min at 12,000Xg at 4°C and the 
supernatant collected and used for co-immunoprecipitation. 20µL of Protein G/A 
agarose suspension was added to the lysate and incubated at 4°C for 1 hour under gentle 
rotary agitation. After centrifugation at 12,000Xg for 1 min, the supernatant was 
collected. 1 µg of polyclonal eNOS antibody was added to the lysate and incubated for 4 
hours at 4°C under gentle rotary agitation.  15µL of Protein G/A agarose suspension was 
then added to the lysate and incubated for 1 hour at 4°C under gentle rotary agitation. 
The eNOS protein complex was then eluted from the lysate, washed three times and 
stored at -80°C in Laemmli buffer for immunoblotting. 
3.2.6 Quantification of Cav1:eNOS, Hsp90:eNOS, and CaM:eNOS interactions 
 Relative differences in eNOS, Cav1, Hsp90, and CaM across age and training 
groups were assessed in aortas using immunoblot analysis as described in detail 
previously (Jasperse and Laughlin 1999). Briefly, protein content was assessed using a 
bicinchoninic acid protein assay. eNOS, Cav1, Hsp90, and CaM protein content was 
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evaluated using monoclonal antibodies (eNOS, Hsp90, and CaM, 1:1250; Cav1, 1:2500). 
Immunoblots were evaluated using enhanced chemiluminescence (ECL, Amersham) and 
densitometry using LAS-4000 Luminescent Image Analyzer and Multi-Gauge Image 
Analysis Software (FUJIFILM Medical Systems).  
3.2.7 Statistical analysis 
 All values are presented as mean ± SE. Two-way ANOVA was used to 
determine between-group differences in body weight, citrate synthase activity, and 
protein:protein interactions. Concentration-response curves were analyzed by two-way 
ANOVA with repeated measures on one factor (dose) to determine whether 
vasorelaxation responses to ACh and SNP differed by group. Concentration-response 
data were expressed as a percentage of maximal possible vasorelaxation. Percent 
possible vasorelaxation was calculated as [(Ddose – DB)/(DP – DB)] X 100, where Ddose is 
measured tension for a given dose, DB is baseline tension of an intervention, and DP is 
maximal passive diameter.  Statistical significance was set at the P≤ 0.05 probability 
level.  
3.3 Results 
3.3.1 Characteristics of rats  
The body weights and citrate synthase activity of the rats used in this study have 
been published previously (Trott et al. 2009). Briefly, Old Sed rats were significantly 
heavier than Young Sed rats. Endurance exercise training significantly lowered body 
weight in Old Ex rats so they were not different from Young Sed or Young Ex rats. As 
reported previously (Trott et al. 2009), citrate synthase activity in the vastus lateralis was 
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significantly increased by training in both young (Young Sed: 29.9 ± 0.7 vs. Young Ex: 
39.7 ± 3.7 µmol · min-1·g wet wt -1, P ≤ 0.05) and old (Old Sed: 25.6 ± 1.8 vs. Old Ex: 
38.7 ± 3.0 µmol · min-1·g wet wt -1, P ≤ 0.05) rats, confirming the efficacy of the training 
protocol.  
3.3.2 Effect of age and exercise training on endothelium-dependent  and –independent 
vasorelaxation 
 3.3.2.1 ACh-induced relaxation 
ACh-induced relaxation was significantly impaired in Old Sed aortas relative to 
Young Sed aortas (Figure. 3.1A). Endurance exercise training significantly improved 
ACh-induced relaxation in old aortas such that ACh-induced relaxation was significantly 
greater in Old Ex than in Old Sed (Figure. 3.1A). In addition, ACh-induced relaxation 
of Old Ex aortas was not different from that of Young Sed aortas (Figure. 3.1A). 
Endurance exercise training also improved relaxation responses in aortas from young 
animals so that Young Ex was significantly greater than Young Sed (Figure. 3.1A). 
All between-group differences in ACh-induced relaxation were abolished in the presence 
of L-NAME to inhibit NOS (Figure. 3.1B). 
??????????????????????????????
There were no significant between-group differences in vasorelaxation responses 
to SNP (Figure. 3.2).  
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3.3.3 Effect of age and exercise training on eNOS associated protein:protein 
interactions 
 Total eNOS protein content was significantly greater in aortas from Old 
compared to Young rats (Figure. 3.3). Cav1:eNOS interaction was significantly lower in 
aortas from Old Sed compared to Young Sed rats (Figure. 3.4). Endurance exercise 
training did not alter Cav1:eNOS interactions in young or old aortas (Figure. 3.4). 
Protein:protein interaction between Hsp90 and eNOS was not altered by age or exercise 
training (Figure. 3.5). CaM:eNOS interaction was significantly lower in aortas from Old 
Sed compared to Young Sed (Figure. 3.6); however, there was no effect of endurance 
training on CaM:eNOS interactions in young or old aortas.  
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Figure 3.1. Acetylcholine (ACh)-induced relaxation in aortic rings in the absence 
(Panel A) or presence (Panel B) of L-NAME (300μM) to inhibit nitric oxide 
synthase.  Sed, sedentary; Ex, exercise trained; Values are means ± SE; n = 10 per 
group.  *Dose-response curve significantly different from all other curves, p ≤ 0.05. 
 
Figure 3.1 
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   Figure 3.2. Sodium nitroprusside (SNP)-induced relaxation in aortic rings.  Sed, 
sedentary; Ex, exercise trained; Values are means ± SE; n = 10 per group.  
Statistical analysis revealed no significant between-group differences. 
 
Figure 3.2 
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Figure 3.3. Total eNOS protein content in aortic rings.  Sed, sedentary; Ex, 
exercise trained.  Inset: representative immunoblot for eNOS. Values are means ± 
SE; n =6-10/group.  *significantly different, p ≤ 0.05. 
Figure 3.3 
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  Figure 3.4. Cav1 association with eNOS.  Antibodies against eNOS were used to 
immunoprecipitate eNOS protein.  The immunoprecipitates were analyzed for 
associated Cav-1 by immunoblot.  Sed, sedentary; Ex, exercise trained.  Inset: 
representative immunoblot for Cav-1. Values are means ± SE. n = 6-10/group.  
*significantly different, p ≤ 0.05. 
Figure 3.4 
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   Figure 3.5. Hsp90 association with eNOS. Antibodies against eNOS were used to 
immunoprecipitate eNOS protein.  The immunoprecipitates were analyzed for 
associated Hsp90 by immunoblot. Sed, sedentary; Ex, exercise trained.  Inset: 
representative immunoblot for Hsp90. Values are means ± SE. n = 6-10/group.  
*significantly different, p ≤ 0.05. 
Figure 3.5 
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   Figure 3.6. CaM association with eNOS. Antibodies against eNOS were used to 
immunoprecipitate eNOS protein.  The immunoprecipitates were analyzed for 
associated CaM by immunoblot. Sed, sedentary; Ex, exercise trained.  Inset: 
representative immunoblot for CaM. Values are means ± SE. n = 6-10/group.  
*significantly different, p ≤ 0.05. 
Figure 3.6 
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3.4 Discussion 
 The purpose of this study was to test the hypothesis that impaired endothelium-
dependent relaxation in aged aorta is due to alterations in protein:protein interactions 
between eNOS and its regulatory proteins resulting in impaired NO-mediated relaxation. 
In addition, we hypothesized that endurance exercise training improves or restores NO-
mediated vasorelaxation in aged aortas by reversing the detrimental effects of aging on 
protein:protein interaction between eNOS and its regulatory proteins. The primary novel 
findings of this study are that: 1) Aging resulted in reduced Cav1:eNOS and CaM:eNOS 
interactions, but had no impact on Hsp90:eNOS interactions, and 2) 10 weeks of 
endurance exercise training did not alter protein:protein interactions among eNOS and 
its key regulatory proteins. Additionally, we confirmed the presence of impaired NO-
mediated,  ACh-induced endothelium-dependent relaxation in Old Sed vs. Young Sed rat 
aortas, and demonstrated that 10 weeks of endurance exercise training completely 
restores NO-mediated, ACh-induced relaxation in aortas from old rats. Together, these 
results suggest that age-associated alterations in the interactions among eNOS and three 
of its key regulatory proteins may be a mechanism accounting for impaired NO-
mediated vasorelaxation in aged arteries. Further, these results indicate that the 
beneficial effect of endurance exercise training in improving NO-mediated ACh-induced 
endothelial function with age is unlikely due to exercise-induced alterations in 
protein:protein interactions among eNOS and Cav1, Hsp90,  or CaM.  
 Endurance exercise training has been shown to improve NO-mediated 
endothelium-dependent relaxation in aged conduit arteries (Delp et al. 1993)  as well as 
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resistance sized arteries and arterioles (Spier et al. 2004; Trott et al. 2009). This in turn 
reduces the risk of developing cardiovascular diseases and helps maintain endurance 
exercise tolerance with age. However, the mechanism(s) accounting for this 
improvement is unclear. There is evidence to suggest that endurance exercise training 
increases eNOS protein content and mRNA expression in aortas, which may enhance 
NO production with aging (Tanabe et al. 2003b); however, increased eNOS expression 
is not always directly associated with increased NO bioavailability (Cernadas et al. 
1998). Indeed, the interaction between eNOS and the regulatory proteins Cav1, Hsp90, 
and CaM play an integral role in regulating NO production by altering eNOS enzyme 
activity. Cav1, a negative allosteric regulator of eNOS activity, binds eNOS on its 
scaffolding domain and reduces eNOS enzyme activity (Ju et al. 1997; Michel et al. 
1997b). When endothelial cells are stimulated with ACh, there is an increase in 
intracellular calcium which activates CaM, which then binds to eNOS causing Cav1 to 
dissociate from eNOS (Michel et al. 1997b). Additionally, Hsp90 binding to eNOS 
facilitates eNOS binding with CaM and dissociation from Cav1 (Brouet et al. 2001).
 In the present study, aging decreased Cav1:eNOS interaction, which was 
contrary to our hypothesis that aging would result in an increase in the interaction 
between these proteins. Additionally, this finding differs from the findings of Smith et al 
(2006), who showed an increase in Cav1:eNOS interaction in aortic endothelial cells 
from old rats compared to young rats. It is important to note however that the rats used 
in our studies were Fischer 344 rats studied at 4 and 24 months, whereas rats used in the 
Smith et al. study were Fischer 344 x Brown Norway cross studied at 4 and  36 months. 
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Thus, strain and age differences may contribute to the differences in Cav1:eNOS data.  
Additionally, we showed a significant age-associated increase in total eNOS protein 
content, which could further affect the total ratio of Cav1 bound eNOS protein, while 
Smith et al showed no difference in total eNOS protein content between young and old 
aorta. Greater eNOS protein content in aged aortas would make detecting small 
differences in Cav1 binding more difficult.   
Interestingly, Piech et al. (2003) showed reduced total Cav1 protein in aortas 
from spontaneously hypertensive rats at both 18 and 63 weeks of age compared to aged-
matched Wistar-Kyoto rats. Similarly, Vera et al. (2007) also demonstrated reduced 
Cav1 protein content as well as elevated eNOS protein content in aortas from 
spontaneously hypertensive rats compared to age-matched Wistar-Kyoto rats.  While 
neither study looked at the interaction between Cav1 and eNOS, it is conceivable that the 
reduced Cav1 protein content and increased eNOS protein content resulted in lower 
Cav1:eNOS interaction in hypertensive animals. Downregulation of Cav1 with 
hypertension would allow NO production to be maintained via elevated eNOS activity as 
a compensatory mechanism against the increase in oxidative stress found in hypertension 
(Piech et al. 2003). Hypertension has previously been described as accelerated aging 
resulting in similar impairments in vascular endothelial function between aging and 
hypertension (Taddei et al. 1997); therefore, it is possible that the reduced Cav1:eNOS 
interaction found in our study is a compensatory mechanism to help preserve eNOS 
enzyme activity and thus, NO production.  
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Results from the present study were consistent with our hypothesis that exercise 
training restores endothelium-dependent relaxation in aged aorta by enhancing NO-
mediated relaxation; however, the beneficial effect of exercise training was not mediated 
by altered protein:protein interactions between eNOS and the three key regulatory 
proteins examined in this study.  While this study focused on Cav1, CaM, and Hsp90, 
eNOS also interacts with other proteins in the endothelium, including Akt, Future studies 
examining the effects of age and endurance exercise training on other eNOS-associated 
proteins in rat aortas are certainly warranted. Additionally, there is evidence indicating 
that aging has a heterogeneous effect throughout the arterial tree on endothelial function. 
While we did not find any effect of exercise training on protein:protein interactions in 
aged aortas, it is possible that in smaller conduit or resistance-sized arteries, the effects 
of exercise training may alter protein:protein interactions between eNOS and Cav1, 
CaM, or Hsp90. 
The mechanism accounting for the training-induced improvement in NO-
mediated relaxation is not clear; however, it is conceivable that exercise training 
enhanced vascular antioxidant capacity in aged aortas. This speculation is supported by 
previous work by Trott et al (2009) indicating that exercise training increased 
extracellular superoxide dismutase protein (ecSOD) content and restored NO-mediated 
endothelium-dependent dilation in skeletal muscle resistance arteries. It is important to 
note that the aortas used in the present study were from the same animals used by Trott 
et al. (2009) to study skeletal muscle resistance arteries. Taken together, these results 
indicate that exercise training restores NO-mediated endothelial function in both conduit 
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and resistance arteries, which may reduce the risk of cardiovascular disease and improve 
exercise tolerance in the elderly. 
In summary, the results of this study indicate that aging impairs NO-mediated, 
endothelium-dependent relaxation in aged aortas. Endurance exercise training reverses 
the detrimental effects of aging on endothelium-dependent relaxation in aortas by 
enhancing NO bioavailability. Contrary to our hypothesis, the enhancement in NO 
bioavailability was not mediated by exercise training-induced alterations in 
protein:protein interactions between eNOS and its regulatory proteins. Further study is 
needed to determine the mechanism accounting for the beneficial effect of exercise 
training on NO-mediated relaxation. 
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CHAPTER IV 
SUMMARY AND CONCLUSIONS 
4.1 Summary and conclusions 
The purpose of this dissertation was to determine the effect of aging on NO-
mediated endothelial function via protein:protein interactions among eNOS and its key 
regulatory proteins throughout the vascular tree and to determine the effect of exercise 
training on eNOS-associated protein:protein interactions with aging in the aorta.  
 The primary purpose of the first study was to examine the age-associated 
changes in Cav1:eNOS and CaM:eNOS interactions throughout the vascular tree, 
including large conduit arteries, small muscular arteries, and resistance-sized skeletal 
muscle arterioles. Given the heterogeneous nature of the arterial network, it was 
hypothesized that the protein:protein interactions examined would vary with vessel type, 
as would the effect of aging on these protein:protein interactions. Additionally, aging has 
been shown to have disparate effects on NO-mediated endothelial function in oxidative 
vs. glycolytic skeletal muscle feed artery and arterioles, further supporting the rationale 
for this study. This may contribute to the altered distribution of skeletal muscle blood 
flow from oxidative to glycoltic muscle, as well as impaired exercise tolerance seen with 
advanced age. The key findings of this study are: 1) there is heterogeneity of eNOS-
associated protein:protein interaction phenotype throughout the arterial network; and 2) 
aging also has a heterogeneous effect on eNOS-associated protein:protein interactions 
throughout the arterial network. 
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While results of this study demonstrate the heterogeneous effect of aging on 
eNOS-associated protein:protein interactions through the arterial network, the 
implications of these alterations are currently unknown. It is likely that the metabolic 
milieu surrounding each branch of the arterial network interacts with the specific 
anatomy of that vessel to optimally regulate arterial tone throughout the arterial tree. 
This study focused on one mechanism as a potential mediator of age-associated 
impairments in NO-mediated endothelial function, but numerous mechanisms appear to 
contribute to the age-related decline in endothelial function. Age-related increases in 
oxidative stress have been shown to impaire NO-mediated endothelial function in soleus 
muscle feed arteries and arterioles, as well as in aortas. Further study is need to 
determine the contribution of both Cav1:eNOS and CaM:eNOS interactions to NO-
mediated endothelial function in each vessel branch both in young healthy vessels and in 
aged vessels. A schematic outlining the key findings from this study is presented in 
Figure 4.1.  
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Figure 4.1.  Schematic outlining changes in Cav1:eNOS and CaM:eNOS with aging. Key: 
↓ interaction decreases with age; ≠ no significant change in interaction with age. 
Figure 4.1 
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The primary purpose of the second study was to determine the effects of aging 
combined with endurance exercise training on NO-mediated endothelial function and 
Cav1:eNOS, Hsp90:eNOS, and CaM:eNOS interaction in rat aortas. Cav1 acts as a 
negative regulator of eNOS activity, thus increasing the amount of eNOS bound to Cav1 
could potentially reduce NO bioavailability. Hsp90 and CaM are both positive regulators 
of eNOS when bound, and have to potential to enhance NO bioavailability. The 
hypotheses for this study were that aging would result in impaired NO-mediated 
vasorelaxation in aged aortas, and that this would be ameliorated with 10 weeks of 
endurance exercise training. Further, aging would increase Cav1:eNOS while reducing 
Hsp90:eNOS and CaM:eNOS interactions, with the effect of limiting NO bioavailability 
in aged aortas. Finally, endurance exercise training would reverse the detrimental effects 
of aging on protein:protein interactions among eNOS and its key regulatory proteins. 
The key findings of this study are that: 1) aging resulted in impaired ACh-induced 
endothelium-dependent relaxation in rat aortas; 2) 10 weeks of endurance exercise 
training completely restored ACh-induced relaxation in aortas from old rats, and; 3) All 
age and exercise effects were abolished in the presence of L-NAME to inhibit NOS; 4) 
Aging resulted in reduced Cav1:eNOS and CaM:eNOS interactions.  These findings are 
consistent with our hypothesis that endurance exercise training mitigates the negative 
effects of aging on NO-mediated endothelial function. Additionally, aging also alters 
Cav1:eNOS and CaM:eNOS interactions, which may ultimately result in impaired NO 
bioavailability. While the decrease in Cav1:eNOS interaction with age found in this 
study appears to contradict previous work, it is possible that the dissociation of eNOS 
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from Cav1 is a compensatory mechanism against impaired NO bioavailability to 
increase eNOS enzyme activity. However, this compensation is not sufficient to restore 
NO bioavailability with age. This suggests that other mechanisms are also present that 
limit NO bioavailability. The finding that aging is associated with reduced CaM:eNOS 
interactions supports our hypothesis, and may be one mechanism that partially accounts 
for the decline in NO bioavailability with aging. Interestingly, we found no effect of 
exercise training on the three protein:protein interactions identified in our study. These 
results suggest that exercise training does not work through these protein:protein 
interactions to restore or maintain NO-mediated vasorelaxation in rat aortas, although 
this finding does not preclude the possibility that other protein:protein interactions 
regulating eNOS activity respond to exercise training. The overall mechanism outlined 
in this study is presented in Figure 4.2. 
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Figure 4.2.  Proposed model of changes in Cav1:eNOS, CaM:eNOS, and Hsp90:eNOS 
with age and exercise training in rat aorta. Aging resulted in a decrease in Cav1:eNOS 
and CaM:eNOS interactions, but had no effect on Hsp90:eNOS interaction. 10 weeks of 
exercise training did not affect protein:protein interactions in either young or old aortas. 
Figure 4.2 
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 Collectively, these two studies highlight the heterogeneous nature of vascular 
aging throughout the arterial network. While the significance of the protein:protein 
interactions identified at each vessel is still a topic for further investigation, these studies 
are a first step in identifying a mechanism that has the potential to regulate NO 
bioavailability with aging. Additionally, the second study emphasizes the beneficial 
effect of endurance exercise training in restoring endothelial function and the role of key 
protein:protein interactions that may be involved in this process.  
4.2 Limitations 
There are some potential limitations to the studies presented in this dissertation 
that should be identified. First, these studies were not designed to mechanistically link 
the protein:protein interactions to NO bioavailability in the vessels we studied. While 
this remains and important link between the studies presented here and confirming the 
role of each protein:protein interaction, the biochemistry used in these studies required a 
significant amount of tissue which precluded the additional studies that would directly 
link changes in protein:protein interactions to changes in NO production. Alternatively, 
knockout animal models or siRNA studies would also yield important insights to the 
questions addressed in this dissertation; however, these methods are cost prohibitive. 
Second, the protein:protein interactions studied in this dissertation are likely only 
a few of the protein:protein interactions that may contribute to regulating NO 
bioavailability. The interactions selected for this dissertation had significant support 
from the existing literature that they directly contribute to eNOS enzyme activity. These 
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interactions should provide a solid foundation for further exploration of this mechanism 
of eNOS regulation. 
Finally, it should be noted that all protein:protein interactions were expressed as 
a ratio of the protein of interest to the immunoprecipitated eNOS. While this is an 
established method of presenting co-immunoprecipitation data, the age-related increase 
in eNOS protein content alone may alter the perceived protein:protein interactions.  
4.3 Clinical relevance 
The studies presented in this dissertation contribute to the development of 
therapeutic practices for older adults in preventing cardiovascular diseases that are 
prevalent with advanced age.  The mechanisms accounting for age-related vascular 
pathologies appear to be specific to vessel type, and the first study in this dissertation 
systematically describes one mechanism in large conduit arteries, small muscular 
arteries, and arterioles. This has important clinical implications in that targeting a 
therapy to a specific vessel type would need to address the specific age-related changes 
in that vessel. Additionally, aerobic exercise has been established as a therapeutic 
strategy against the age-related decline in endothelial function, and the second study in 
this dissertation investigates a potential mechanism for preventing the age-related 
decline in endothelial function. While the findings in this study did not support our 
hypothesis, it is an important step in elucidating the mechanisms and pathways 
responsible for the protective effect of exercise training on vascular function.  
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APPENDIX 
RAW DATA TABLES 
Table 1. Densitometry Values for eNOS blots (Figure 2.1) 
Vessel Number Age eNOS 
Aorta 15874 Old 2828920 
Aorta 15948 Old 1923284 
Aorta 16077 Old 3569511 
Aorta 16144 Old 3236856 
Aorta 16219 Old 17928111 
Aorta 16291 Old 4056471 
Aorta 16365 Old 9856451 
Aorta 15913 Young 2443182 
Aorta 16039 Young 3172144 
Aorta 16110 Young 3021445 
Aorta 16182 Young 2133846 
Aorta 16255 Young 3059072 
Aorta 16329 Young 1516620 
Aorta 16398 Young 1004033 
Iliac 15805 Old 7970618 
Iliac 15873 Old 5950400 
Iliac 15947 Old 6175762 
Iliac 16076 Old 6276924 
Iliac 16143 Old 11948013 
Iliac 16218 Old 6698636 
Iliac 16289 Old 10668341 
Iliac 16364 Old 13678472 
Iliac 15775 Young 6773347 
Iliac 15838 Young 6386039 
Iliac 15912 Young 6222876 
Iliac 16038 Young 9994104 
Iliac 16109 Young 23277389 
Iliac 16181 Young 15860946 
Iliac 16254 Young 13695375 
Iliac 16378 Young 16822028 
Femoral 16363 Old 2867606 
Femoral 16292 Old 2773075 
Femoral 16217 Old 3539420 
Femoral 16142 Old 4025345 
Femoral 16075 Old 7357889 
Femoral 15806 Old 6938630 
Femoral 15872 Old 6433945 
 
96 
 
Table 1 continued 
Vessel Number Age eNOS 
Femoral 16327 Young 2692977 
Femoral 16253 Young 2482668 
Femoral 16180 Young 2462662 
Femoral 16108 Young 4630007 
Femoral 15774 Young 7283229 
Femoral 15837 Young 7756749 
Femoral 16037 Young 7285422 
Femoral 15911 Young 6846572 
GFA 7 Old 12426416 
GFA 5 Old 10450606 
GFA 3 Old 7370194 
GFA 1 Old 10328952 
GFA 15 Old 7376028 
GFA 13 Old 6643516 
GFA 11 Old 5056720 
GFA 9 Old 4863231 
GFA 8 Young 11246731 
GFA 6 Young 11274101 
GFA 4 Young 8850318 
GFA 2 Young 9581397 
GFA 18 Young 4874365 
GFA 16 Young 4845079 
GFA 14 Young 5381467 
GFA 10 Young 6775859 
SFA pooled Old 5666621 
SFA pooled Old 22139333 
SFA pooled Old 8502373 
SFA pooled Young 4902018 
SFA pooled Young 8425816 
SFA pooled Young 9569936 
G1A pooled Old 5391149 
G1A pooled Old 1569306 
G1A pooled Young 5637504 
G1A pooled Young 1586974 
RG2A pooled Old 1762991 
RG2A pooled Old 4526804 
RG2A pooled Young 7398481 
RG2A pooled Young 1733702 
RG3A pooled Old 7860769 
RG3A pooled Young 9215108 
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Table 1 continued 
Vessel Number Age eNOS 
S1A pooled Old 2254486 
S1A pooled Old 9133601 
S1A pooled Old 14327350 
S1A pooled Young 13521671 
S1A pooled Young 11053543 
S1A pooled Young 1584752 
S2A pooled Old 7437848 
S2A pooled Old 9269667 
S2A pooled Young 8401487 
S2A pooled Young 20368074 
S3A pooled Old 6056566 
S3A pooled Old 6966707 
S3A pooled Young 5161176 
S3A pooled Young 7188974 
WG2A pooled Old 1676769 
WG2A pooled Old 4410586 
WG2A pooled Young 5820028 
WG2A pooled Young 1628935 
WG3A pooled Old 5501194 
WG3A pooled Old 4824983 
WG3A pooled Young 5727700 
WG3A pooled Young 4213827 
WG3A pooled Young 11618746 
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 Table 2.  Densitometry Values for eNOS and Cav1 (Figure 2.2) 
Vessel Number Age eNOS Cav1 
Aorta 15874 Old 2828920 2724901 
Aorta 15948 Old 1923284 2628082 
Aorta 16077 Old 3569511 2537707 
Aorta 16144 Old 3236856 2434376 
Aorta 16219 Old 17928111 8026812 
Aorta 16291 Old 4056471 1401681 
Aorta 16365 Old 9856451 3301940 
Aorta 15913 Young 2443182 1318106 
Aorta 16039 Young 3172144 5298554 
Aorta 16110 Young 3021445 4468438 
Aorta 16182 Young 2133846 1272840 
Aorta 16255 Young 3059072 3754594 
Aorta 16329 Young 1516620 1277201 
Aorta 16398 Young 1004033 993433 
Iliac 15805 Old 7970618 9006488 
Iliac 15873 Old 5950400 7002914 
Iliac 15947 Old 6175762 4947751 
Iliac 16076 Old 6276924 5061395 
Iliac 16143 Old 11948013 42642165 
Iliac 16218 Old 6698636 37408155 
Iliac 16289 Old 10668341 32935413 
Iliac 16364 Old 13678472 31699221 
Iliac 15775 Young 6773347 5710401 
Iliac 15838 Young 6386039 5153780 
Iliac 15912 Young 6222876 4953175 
Iliac 16038 Young 9994104 4763558 
Iliac 16109 Young 23277389 29464088 
Iliac 16181 Young 15860946 35763658 
Iliac 16254 Young 13695375 47782036 
Iliac 16378 Young 16822028 34374906 
Femoral 16363 Old 2867606 18343165 
Femoral 16292 Old 2773075 14391302 
Femoral 16217 Old 3539420 18206724 
Femoral 16142 Old 4025345 20132448 
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Table 2 continued 
Vessel Number Age eNOS Cav1 
Femoral 16075 Old 7357889 9270321 
Femoral 15806 Old 6938630 15309039 
Femoral 15872 Old 6433945 11069955 
Femoral 16327 Young 2692977 27419389 
Femoral 16253 Young 2482668 25524759 
Femoral 16180 Young 2462662 23293371 
Femoral 16108 Young 4630007 17817320 
Femoral 15774 Young 7283229 6203727 
Femoral 15837 Young 7756749 8607567 
Femoral 16037 Young 7285422 14637828 
Femoral 15911 Young 6846572 13341706 
GFA 7 Old 12426416 14625941 
GFA 5 Old 10450606 9120073 
GFA 3 Old 7370194 8511867 
GFA 1 Old 10328952 11432762 
GFA 15 Old 7376028 15540888 
GFA 13 Old 6643516 26228304 
GFA 11 Old 5056720 29890991 
GFA 9 Old 4863231 28359450 
GFA 8 Young 11246731 15301255 
GFA 6 Young 11274101 18113111 
GFA 4 Young 8850318 10352756 
GFA 2 Young 9581397 19539012 
GFA 18 Young 4874365 32206090 
GFA 16 Young 4845079 22814729 
GFA 14 Young 5381467 33998320 
GFA 10 Young 6775859 18973901 
SFA pooled Old 5666621 8473560 
SFA pooled Old 22139333 9151252 
SFA pooled Old 8502373 11368721 
SFA pooled Young 4902018 7787865 
SFA pooled Young 8425816 10175429 
SFA pooled Young 9569936 11236060 
G1A pooled Old 5391149 19172758 
G1A pooled Old 1569306 4713403 
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Table 2 continued 
Vessel Number Age eNOS Cav1 
G1A pooled Young 5637504 22840103 
G1A pooled Young 1586974 1846285 
RG2A pooled Old 1762991 1860192 
RG2A pooled Old 4526804 5315115 
RG2A pooled Young 7398481 9145797 
RG2A pooled Young 1733702 1829316 
RG3A pooled Old 7860769 33688121 
RG3A pooled Young 9215108 21754864 
S1A pooled Old 2254486 5178818 
S1A pooled Old 9133601 10141183 
S1A pooled Old 14327350 9999012 
S1A pooled Young 13521671 8626727 
S1A pooled Young 11053543 11514302 
S1A pooled Young 1584752 11007980 
S2A pooled Old 7437848 25372234 
S2A pooled Old 9269667 24451830 
S2A pooled Young 8401487 20579520 
S2A pooled Young 20368074 25863860 
S3A pooled Old 6056566 30087603 
S3A pooled Old 6966707 18447460 
S3A pooled Young 5161176 27747941 
S3A pooled Young 7188974 27438713 
WG2A pooled Old 1676769 3161708 
WG2A pooled Old 4410586 8634514 
WG2A pooled Young 5820028 12657266 
WG2A pooled Young 1628935 2166767 
WG3A pooled Old 5501194 15311870 
WG3A pooled Old 4824983 8793057 
WG3A pooled Young 5727700 33830972 
WG3A pooled Young 4213827 10358772 
WG3A pooled Young 11618746 34089564 
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Table 3. Densitometry Values for eNOS and CaM (Figure 2.3) 
Vessel Number Age eNOS CaM 
Aorta 15874 Old 2828920 2125807 
Aorta 15948 Old 1923284 2100519 
Aorta 16077 Old 3569511 3910874 
Aorta 16144 Old 3236856 3855000 
Aorta 16291 Old 4056471 5142228 
Aorta 16365 Old 9856451 3086545 
Aorta 15913 Young 2443182 3024550 
Aorta 16110 Young 3021445 5300122 
Aorta 16182 Young 2133846 3485898 
Aorta 16255 Young 3059072 4115113 
Aorta 16329 Young 1516620 3945496 
Aorta 16398 Young 1004033 1213614 
Iliac 16143 Old 11948013 22456561 
Iliac 16218 Old 6698636 27920996 
Iliac 16289 Old 10668341 16647457 
Iliac 16364 Old 13678472 18596692 
Iliac 16109 Young 23277389 19182726 
Iliac 16181 Young 15860946 21260530 
Iliac 16254 Young 13695375 24494047 
Iliac 16378 Young 16822028 23099979 
Femoral 16363 Old 2867606 1930475 
Femoral 16292 Old 2773075 1720049 
Femoral 16217 Old 3539420 1834612 
Femoral 16142 Old 4025345 1536532 
Femoral 16075 Old 7357889 53682099 
Femoral 15806 Old 6938630 63942643 
Femoral 15872 Young 6433945 51135785 
Femoral 16327 Young 2692977 2170651 
Femoral 16253 Young 2482668 2031393 
Femoral 16180 Young 2462662 1706425 
Femoral 16108 Young 4630007 1694377 
Femoral 15774 Young 7283229 31361392 
Femoral 15837 Young 7756749 49691139 
Femoral 16037 Young 7285422 67135353 
Femoral 15911 Old 6846572 53058669 
 
102 
 
Table 3 continued 
Vessel Number Age eNOS CaM 
GFA 7 Old 12426416 12747217 
GFA 5 Old 10450606 9862242 
GFA 3 Old 7370194 8996341 
GFA 1 Old 10328952 8785893 
GFA 15 Old 7376028 22188254 
GFA 13 Old 6643516 53280851 
GFA 11 Young 5056720 46107120 
GFA 9 Young 4863231 34361961 
GFA 8 Young 11246731 14138121 
GFA 6 Young 11274101 20810655 
GFA 4 Young 8850318 9736387 
GFA 2 Young 9581397 19028701 
GFA 18 Young 4874365 44480277 
GFA 16 Young 4845079 19263151 
GFA 14 Old 5381467 22595499 
GFA 10 Old 6775859 21576540 
SFA pooled Old 5666621 90658644 
SFA pooled Old 22139333 73301037 
SFA pooled Old 8502373 83098934 
SFA pooled Old 4902018 72517932 
SFA pooled Old 8425816 100124821 
SFA pooled Old 9569936 82743612 
G1A pooled Young 5391149 5776373 
G1A pooled Young 1569306 14194830 
G1A pooled Young 5637504 7797078 
G1A pooled Young 1586974 11632034 
RG2A pooled Young 1762991 3733297 
RG2A pooled Young 1733702 3636034 
RG3A pooled Old 7860769 63189084 
RG3A pooled Old 9215108 35977085 
S1A pooled Old 2254486 32054805 
S1A pooled Old 1584752 11572378 
S2A pooled Young 7437848 6206463 
S2A pooled Young 9269667 36976506 
S2A pooled Old 8401487 5563065 
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Table 3 continued 
Vessel Number Age eNOS CaM 
S2A pooled Old 20368074 44311017 
S3A pooled Young 6056566 6326281 
S3A pooled Young 6966707 52039590 
S3A pooled Old 5161176 7277516 
S3A pooled Young 7188974 56831175 
WG2A pooled Old 1676769 10121292 
WG2A pooled Young 1628935 6228604 
WG3A pooled Young 5501194 31709004 
WG3A pooled Old 5727700 8961357 
WG3A pooled Young 11618746 55929091 
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Table 4. Densitometry Values for eNOS blots (Figure 3.3) 
Animal Vessel Number Group eNOS 
192 23692 Ysed 11086467 
196 23789 Ysed 6861357 
197 averaged Ysed 3961956.5 
198 averaged Ysed 3737037.5 
201 23903 Ysed 4137772 
222 averaged Ysed 2235769.5 
223 averaged Ysed 2687555 
224 24395 Ysed 3494156 
228 24474 Ysed 5378254 
199 23866 Yex 5916685 
200 23889 Yex 4107935 
202 averaged Yex 13145313.5 
203 averaged Yex 5535622.5 
209 averaged Yex 2842291 
210 24113 Yex 2244742 
218 24280 Yex 4510037 
221 24336 Yex 3535956 
225 24417 Yex 3679454 
187 23601 Osed 11822782 
188 23617 Osed 11402838 
193 23731 Osed 14271160 
194 23750 Osed 4287122 
205 averaged Osed 8244826 
207 averaged Osed 2376102 
208 24082 Osed 8020135 
213 24186 Osed 14527918 
226 24435 Osed 3932943 
227 24455 Osed 15119998 
211 24142 Oex 40561747 
212 averaged Oex 5962293 
214 averaged Oex 11278278 
215 averaged Oex 15980545.33 
216 averaged Oex 5778732 
217 averaged Oex 4612531.667 
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Table 5. Densitometry Values for eNOS and Cav1 (Figure 3.4) 
Animal Vessel Group eNOS intensity Cav1 intensity 
192 23692 Ysed 11086467 0.30576621 
196 23789 Ysed 6861357 0.510242362 
197 averaged Ysed 3961956.5 1.359136671 
198 averaged Ysed 3737037.5 1.153844253 
201 23903 Ysed 4137772 0.57324594 
222 averaged Ysed 2235769.5 1.124300323 
223 averaged Ysed 2687555 0.955492204 
224 24395 Ysed 3494156 1.692102184 
228 24474 Ysed 5378254 1.312982801 
199 23866 Yex 5916685 0.628006392 
200 23889 Yex 4107935 0.842806179 
202 averaged Yex 13145313.5 0.53769847 
203 averaged Yex 5535622.5 0.978038749 
209 averaged Yex 2842291 0.953043408 
210 24113 Yex 2244742 1.092084079 
218 24280 Yex 4510037 0.498074406 
221 24336 Yex 3535956 2.021260163 
225 24417 Yex 3679454 1.410382356 
187 23601 Osed 11822782 0.310732026 
188 23617 Osed 11402838 0.297441479 
193 23731 Osed 14271160 0.328127076 
194 23750 Osed 4287122 0.921074091 
205 averaged Osed 8244826 0.636914073 
207 averaged Osed 2376102 1.164842819 
208 24082 Osed 8020135 0.299970013 
213 24186 Osed 14527918 0.429327175 
226 24435 Osed 3932943 0.664613751 
227 24455 Osed 15119998 0.537428775 
211 24142 Oex 40561747 0.109384761 
212 averaged Oex 5962293 0.513639796 
214 averaged Oex 11278278 0.431452868 
215 averaged Oex 15980545.33 0.341190042 
216 averaged Oex 5778732 0.746789539 
217 averaged Oex 4612531.667 0.911300599 
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Table 6. Densitometry Values for eNOS and Hsp90 (Figure 3.5) 
Animal Vessel Group eNOS Hsp90 
197 23807 Ysed 2649704 2243425 
198 23846 Ysed 2705715 2219985 
201 23903 Ysed 4137772 2387207 
223 24379 Ysed 3984216 2308077 
224 24395 Ysed 3494156 1602664 
228 24474 Ysed 5378254 1604505 
202 23922 Yex 8581855 6002440 
203 23942 Yex 2254479 1969533 
218 24280 Yex 4510037 2452282 
221 24336 Yex 3535956 1551894 
225 24417 Yex 3679454 1610468 
193 23731 Osed 14271160 11118482 
194 23750 Osed 4287122 3168677 
208 24082 Osed 8020135 2623391 
213 24186 Osed 14527918 1727029 
226 24435 Osed 3932943 2511840 
227 24455 Osed 15119998 1970311 
212 24163 Oex 5609000 2434281 
214 24202 Oex 11066434 7644666 
215 averaged Oex 13811122 6302875 
216 24244 Oex 7403776 1695894 
217 24251 Oex 7736602 1573572 
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Table 7. Densitometry Values for eNOS and CaM (Figure 3.6) 
Animal Vessel Group eNOS CaM 
192 23692 Ysed 11086467 2368471 
196 23789 Ysed 6861357 2009716 
224 24395 Ysed 3494156 3363603 
228 24474 Ysed 5378254 3492440 
199 23866 Yex 5916685 1975547 
200 23889 Yex 4107935 1949793 
221 24336 Yex 3535956 3855570 
225 24417 Yex 3679454 3240862 
186 23601 Osed 11822782 2562151 
197 23617 Osed 11402838 2084239 
213 24186 Osed 14527918 2632914 
227 24455 Osed 15119998 3334562 
211 24142 Oex 40561747 2511489 
212 24161 Oex 6315586 2355425 
216 24244 Oex 7403776 3116903 
217 24251 Oex 7736602 2725558 
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